[
    "This sample is a phase 1/phase 2 trial for patients with Ewing's sarcoma, soft tissue sarcoma, neuroblastoma, and brain tumors, testing the use of plerixafor as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial that aims to evaluate the safety and efficacy of the drugs mk-7145, furosemide, and torsemide in patients with renal impairment and heart failure, who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for small cell lung cancer, testing the drug chloroquine, with specific eligibility criteria including disease stage, performance status, blood counts, renal and hepatic function, lung function, and cardiac health.",
    "This sample is a phase 1 clinical trial testing the use of dasatinib, a drug, in patients who have undergone ASCT for the treatment of hematologic malignancies such as multiple myeloma, Hodgkin's and non-Hodgkin's lymphoma. The eligibility criteria include specific medical conditions, performance status, and laboratory values.",
    "This sample is a phase 1 clinical trial for alcohol dependence, testing the drug citalopram, and includes eligibility criteria for both alcohol-dependent participants and healthy controls.",
    "This sample is a phase 1 clinical trial for cystic fibrosis patients who are homozygous for the F508del-CFTR gene, and it will test the drugs n6022 and normal saline to assess their effectiveness in improving various health parameters such as sweat chloride levels, lung function, and body weight.",
    "This phase 1 trial is testing the drug theophylline in patients with non-small cell lung cancer (NSCLC) who have failed previous palliative therapy, and have specific eligibility criteria including measurable disease, stable brain metastasis, and certain laboratory parameters.",
    "This sample is a phase 1 clinical trial testing the drugs gsk1322322 and moxifloxacin for the treatment of bacterial infections, with specific eligibility criteria for participants.",
    "This sample is a phase 1/phase 2 clinical trial for patients with grade four Glioblastoma Multiforme, testing the effectiveness of the drug Sativex compared to a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with moderate to severe Crohn's Disease who have not responded to previous treatments, and it aims to evaluate the effectiveness of high-dose cyclophosphamide as a potential therapy.",
    "This sample is a phase 1 clinical trial for patients with metastatic melanoma, testing the combination of ipilimumab and isoniazid as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for adult acute myeloid leukemia (AML) patients, testing the combination of metformin hydrochloride and cytarabine as a potential treatment option for relapsed/refractory disease or refractory to conventional induction chemotherapy.",
    "This sample is a phase 1 clinical trial for patients with pancreatic neoplasms, testing the use of ascorbate and gemcitabine as potential treatments, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with relapsed or progressive multiple myeloma, testing the efficacy of combination therapy in patients who have received 1-4 prior treatment regimens, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with relapsed or refractory cutaneous T-cell lymphoma, testing the drugs Istodax and Doxil, with eligibility criteria including biopsy-proven disease, specific laboratory test results, and exclusion criteria such as serious medical conditions and prior organ transplants.",
    "This sample is a phase 1 clinical trial for adult acute myeloid leukemia (AML) patients with relapsed disease or refractory to induction chemotherapy, testing the efficacy of lenalidomide, mitoxantrone hydrochloride, etoposide, and cytarabine as treatment options.",
    "This sample is a clinical trial study that aims to evaluate the effectiveness of romidepsin and placebo for romidepsin in treating HIV infections in patients who meet specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the drug pqr309, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease, with specific eligibility criteria including prior treatment, organ function, and exclusion of certain conditions.",
    "This sample is a phase 1 clinical trial testing the drugs gsk1322322 and ee/ne in combination for the treatment of bacterial infections, with specific eligibility criteria for female participants.",
    "This sample is a phase 1 trial for patients with resectable pancreatic carcinoma, testing the use of metformin hydrochloride as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for healthy individuals, testing the drugs pf-06282999 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for pediatric patients with sickle cell disease, testing the effectiveness of hydroxyurea as a treatment option.",
    "This sample is a phase 1 trial for the treatment of schizophrenia, testing the drugs sep-363856, amisulpride, and placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1 clinical trial for patients with head and neck squamous cell carcinoma, testing the drug Sativex for its potential to alleviate oral mucositis caused by radiotherapy and chemotherapy.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors, testing the combination of lurbinectedin and cisplatin as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for the treatment of migraine, testing the drug pf-05180999 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for diabetic macular edema, testing the effectiveness of ranibizumab injections in patients who have previously received bevacizumab injections, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial investigating the use of clonidine and ropivacaine for postoperative analgesia in patients undergoing foot or ankle surgery with popliteal nerve block planned. The eligibility criteria include being an adult (19 years or older) and classified as ASA class 1, 2, or 3.",
    "This sample is a phase 1/phase 2 trial for hepatocellular carcinoma (HCC) patients, testing the efficacy of the drug Tepotinib in participants with MET+ status, who have either intermediate HCC of BCLC Stage B or advanced HCC of BCLC Stage C, and have disease progression on or intolerance to prior standard treatment for advanced HCC.",
    "This sample is a phase 1/phase 2 trial for post-menopausal women with estrogen receptor positive breast cancer, testing the drugs azd5363, placebo, and fulvestrant, with various inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin and a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the efficacy of canagliflozin and placebo in combination with metformin or a DPP-4 inhibitor, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with chronic lymphocytic leukemia and mantle cell lymphoma, testing the drugs ublituximab and ibrutinib, with specific eligibility criteria for enrollment.",
    "This sample is a phase 1/phase 2 clinical trial for peripheral T-cell lymphoma, testing the drug pralatrexate injection in Japanese patients with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with non-small-cell lung carcinoma, testing the drug lenalidomide as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for the treatment of Rett syndrome using glatiramer acetate (Copaxone\u00ae), with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory multiple myeloma, testing the effectiveness of the drugs palbociclib, dexamethasone, and lenalidomide, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for children, adolescents, and young adults with Prader-Willi syndrome, testing the drugs dccr and placebo. The inclusion criteria include genetically confirmed Prader-Willi syndrome, age between 10 and 22 years, BMI exceeding the 95th percentile, fasting glucose \u2264 126 mg/dL, and HbA1c \u2264 6.5%. The exclusion criteria include recent use of investigational drugs, anticipated use of prohibited medications, history of allergic reaction to certain drugs, anticipated disruptive changes in care, congestive heart failure or compromised cardiac reserve, and any other clinically significant diseases interfering with the assessment of the investigational drug.",
    "This sample is a phase 1 clinical trial for acute coronary syndrome, testing the drugs clopidogrel, aspirin, apd791, and placebo, with eligibility criteria including age, weight, gender, medical history, and consent.",
    "This phase 1 trial is testing the drugs placebo to bi 1026706, pregabalin, bi 1026706, and celecoxib on healthy males aged 18 to 55 years with a BMI of 18.5 to 29.9 kg/m2, and the eligibility criteria include normal medical examination results and blood pressure, as well as no concomitant diseases or gastrointestinal surgeries.",
    "This sample is a phase 1/phase 2 trial for patients with adenocarcinoma of the pancreas, testing the drugs mk-1775 and gemcitabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) and an ALK rearrangement. The drug being tested is ldk378, and the eligibility criteria include having stage IIIB or IV NSCLC and having had progressive disease during or after crizotinib treatment.",
    "This sample is a phase 1 clinical trial for patients with recurrent colon or rectal cancer who have progressed or failed following previous chemotherapy regimens, and it will test the effectiveness of MEK inhibitor MEK162, leucovorin calcium, fluorouracil, and oxaliplatin as treatment options. The eligibility criteria include specific disease requirements, measurable disease size, and various health parameters.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing the drugs melphalan and filgrastim (g-csf) in patients who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial that aims to evaluate the effectiveness of cladribine, cytarabine, and mitoxantrone hydrochloride in treating various types of acute myeloid leukemia and myelodysplastic syndrome, with specific eligibility criteria for patient inclusion.",
    "This sample is a phase 1 trial for patients with chronic myelogenous leukemia (CML) who have inadequate response to TKIs, and it involves the use of zileuton and dasatinib as potential treatments. The eligibility criteria include age > 18, specific performance status, normal liver and kidney function, and the exclusion criteria include certain medical conditions and allergies to the drugs.",
    "This sample is a phase 1/phase 2 trial for depression, testing the drugs diazoxide and placebo, with eligibility criteria including age, negative pregnancy test, fulfillment of DSM-IV criteria for MDD, lack of response to two antidepressant trials, and exclusion criteria including psychotic features, substance abuse, head injury, and serious medical illnesses.",
    "This sample is a phase 1 trial for the drug mek162 in subjects with hepatic impairment, with specific inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 1/phase 2 trial testing the drug sage-547 for the treatment of super-refractory status epilepticus, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the effectiveness of cetuximab and methotrexate as a systemic treatment for recurrent or metastatic disease, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with advanced, progressive, recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma, testing the effectiveness of pazopanib and fosbretabulin as treatment options. The eligibility criteria include specific disease criteria, performance status, measurable disease, and various hematological and biochemical indices.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory B-cell lymphoma, testing the efficacy of ibrutinib and immunochemotherapies, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory multiple myeloma, testing the efficacy of carfilzomib as a treatment option. The eligibility criteria include age, consent, contraception requirements, disease status, performance status, and various laboratory values. Exclusion criteria include pregnancy, active infections, heart failure, peripheral neuropathy, allergies to certain medications, and other clinically significant illnesses.",
    "This sample is a phase 1 trial for patients with acute myeloid leukemia (AML) who have not achieved complete remission after induction therapy or have relapsed. The study aims to evaluate the effectiveness of busulfan, fludarabine phosphate, cyclophosphamide, and tocilizumab in combination with HLA-haploidentical donor stem cell transplantation. Eligibility criteria include specific disease characteristics, available HLA-haploidentical donor, good health, and adequate organ function. Exclusion criteria include high blast count, HIV or active hepatitis infection, hypersensitivity to study agents, recent use of investigational or intensive chemotherapy drugs, pregnancy or breastfeeding, and uncontrolled intercurrent illness.",
    "This phase 1 trial is testing the drugs \"gsk2793660 solution\", \"gsk2793660 capsule\", \"placebo solution\", and \"placebo capsule\" for the treatment of bronchiectasis, with inclusion criteria including being healthy, aged 18-55, and having a body weight >=50 kg and BMI within the range 19.9-30.0 kg/m^2.",
    "This sample is a phase 1 trial for patients with unresectable lung cancer, testing the combination of paclitaxel and carboplatin as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with HER2-positive breast cancer, testing the combination of ganetespib and paclitaxel, with eligibility criteria including prior hormone therapy, specific laboratory values, and exclusion criteria such as prior chemotherapy in the metastatic setting and history of intolerance to trastuzumab or pertuzumab.",
    "This sample is a phase 1 clinical trial for patients with cutaneous T-cell lymphoma, testing the effectiveness of romidepsin and poly iclc drugs in treating the disease, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with prostate cancer, testing the drug AZD2014, and includes eligibility criteria such as age, performance status, diagnosis, and exclusion criteria such as contraindications to the drug, previous treatments, and medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic melanoma and brain metastases, testing the effectiveness of nab-paclitaxel, temozolomide, and bevacizumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with atrial fibrillation, testing the drugs opc-108459 and placebo, with inclusion criteria including recent or new onset of AF and treatment according to the \"Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2008)\", and exclusion criteria including certain heart conditions and history of stroke or myocardial infraction.",
    "This sample is a phase 1 trial for patients with stage IV or locally advanced cancers, testing the efficacy of cyclophosphamide and fludarabine phosphate in combination with NY-ESO-1 positive malignancy and HLA-A*0201 positivity, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs chloroquine, carboplatin, and gemcitabine for the treatment of malignant neoplasms and solid tumors, with specific eligibility criteria for patients with metastatic or unresectable malignancies.",
    "This sample is a phase 1/phase 2 trial for patients with unresectable Stage III or Stage IV melanoma, testing the combination of indoximod, ipilimumab, nivolumab, and pembrolizumab as a systemic treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial testing the drug AG-120 in patients with various IDH1-mutated hematologic malignancies, including relapsed or refractory acute myeloid leukemia (AML) and myelodysplastic syndromes. The eligibility criteria include age \u226518, documented IDH1 R132 gene mutation, ECOG PS of 0-2, and adequate hepatic and renal function. Exclusion criteria include recent hematopoietic stem cell transplant, recent systemic anticancer therapy or investigational agent, pregnancy or breastfeeding, and certain cardiac conditions.",
    "This sample is a phase 1 trial for patients with stage IV, HER2 negative breast cancer, testing the efficacy of different doses of crixotinib and sunitinib in combination as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic pancreatic adenocarcinoma or metastatic pancreatic cancer, testing the combination of nab-paclitaxel, gemcitabine, and indoximod as a treatment option. The eligibility criteria include specific requirements for patient diagnosis, previous treatments, performance status, and exclusion of brain metastases or locally advanced disease.",
    "This sample is a phase 1 trial for patients with cancer who have inadequately controlled pain even with the use of morphine, and are requiring at least 180 mg of morphine per day. The study will test the effectiveness of morphine and oxcarbazepine in managing their pain.",
    "This sample is a phase 1/phase 2 trial for Alzheimer's disease, testing the drugs iti-007 and placebo on healthy geriatric volunteers and geriatric patients with dementia, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with adult brain glioblastoma or glioblastoma multiforme, testing the drug bevacizumab. The eligibility criteria include age, histological confirmation of the disease, evidence of tumor recurrence or progression, and various organ function requirements.",
    "This sample is a phase 1/phase 2 clinical trial for patients with chronic myeloid leukemia who have failed or demonstrated intolerance to prior treatments with tyrosine kinase inhibitors. The trial aims to evaluate the efficacy and safety of omacetaxine mepesuccinate as a potential treatment option.",
    "This sample is a phase 1 trial for schizophrenia patients who are on stable doses of second generation antipsychotics, and the study will test the efficacy of roflumilast, placebo, and second generation antipsychotic drugs in treating the disease. The eligibility criteria include meeting schizophrenia criteria, having cognitive impairment, being between 18 and 55 years old, and meeting certain symptom criteria.",
    "This sample is a phase 1 trial testing the drug semaglutide versus placebo in patients with diabetes, metabolism and nutrition disorder, and obesity, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for lupus erythematosus and graft-versus-host disease, testing the effectiveness of drugs such as cyclophosphamide, fludarabine, tacrolimus, mycophenolate mofetil, and rabbit antithymocyte globulin, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase I clinical trial for patients with relapsed/refractory EBV(+) or KSHV(+) malignancies, testing the drug nelfinavir, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with platinum-resistant ovarian cancer, testing the drug docetaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase I trial investigating the use of ketamine and saline in adults with social anxiety disorder, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with steroid refractory graft versus host disease (GVHD), testing the drug lde225 to determine its effectiveness in treating chronic GVHD.",
    "This sample is a phase 1 clinical trial for ovarian cancer patients with recurrent platinum-sensitive disease, testing the combination of omp-54f28, paclitaxel, and carboplatin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory AML, testing the efficacy of brentuximab vedotin and 5-azacytidine in combination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for Parkinson's disease patients, testing the effectiveness of levodopa and carbidopa in improving morning \"OFF\" symptoms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial investigating the use of milrinone, esmolol, and saline infusion in patients with myocardial reperfusion injury, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing the effectiveness of plitidepsin, bortezomib, and dexamethasone as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for chronic lymphocytic leukemia, testing the combination of tgr-1202, obinutuzumab, and chlorambucil as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma in relapse or refractory multiple myeloma, testing the effectiveness of pomalidomide, marizomib, and low-dose dexamethasone as treatment options. The eligibility criteria include having previously received anti-myeloma therapy with lenalidomide and bortezomib, and having documented disease progression.",
    "This sample is a phase 1 clinical trial that aims to evaluate the safety and efficacy of the drug biib059 compared to a placebo in participants with systemic lupus erythematosus and healthy volunteers, with specific inclusion and exclusion criteria for each group.",
    "This sample is a phase 1 clinical trial testing the drug ibrutinib in patients with various types of B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia, and multiple myeloma who also have HIV infection. The eligibility criteria include specific disease classifications, prior treatment history, HIV documentation, and certain laboratory",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic pancreatic cancer, testing the drug paclitaxel bound albumine. The eligibility criteria include age between 18 and 75, histological evidence of pancreatic ductal adenocarcinoma, measurable metastatic disease, ECOG performance status of 0 or 1, and adequate organ function. Exclusion criteria include age 76 or older, endocrine or acinar pancreatic carcinoma, previous radiotherapy for measurable lesions, central nervous system metastasis, and other concomitant cancers.",
    "This phase 1 trial aims to evaluate the efficacy of ficlatuzumab and cytarabine in treating relapsed or refractory acute myeloid leukemia (AML) patients, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with recurrent or second primary squamous cell head and neck cancer, testing the drug docetaxel. The eligibility criteria include previous head and neck radiation, defined area of recurrence on imaging, and a minimum estimated survival of 3 months.",
    "This sample is a phase 1 clinical trial for individuals with Autism Spectrum Disorder, testing the effectiveness of two drugs, dmxb-a 150 mg and dmxb-a 75 mg, on participants who meet specific inclusion criteria such as age, DSM-5 criteria for Autism Spectrum Disorder, and non-smoking status.",
    "This sample is a phase 1 trial for chronic hepatitis B, testing the drugs nvr 3-778, placebo for nvr 3-778, and pegasys, with eligibility criteria for healthy volunteers and patients with HBeAg positive chronic hepatitis B.",
    "This sample is a phase 1/phase 2 trial testing the efficacy of a cocktail of E. coli and Pseudomonas aeruginosa phages, along with silver sulfadiazine, in treating wound infections caused by these bacteria in burn patients.",
    "This sample is a phase 1 trial for the treatment of advanced intra-ocular retinoblastoma and retinoblastoma using drugs such as melphalan, carboplatin, etoposide, and vincristine, with specific eligibility criteria including age, previous treatment history, and adequate organ function.",
    "This sample is a phase 1 trial for patients with pulmonary hypertension and cardiac MRI <40, testing the effectiveness of carvedilol, a beta blocker, in treating WHO category 1 pulmonary arterial hypertension. The inclusion criteria include age >18, WHO functional class II-III, RVEF by cardiac MRI <40%, and mean pulmonary artery pressure >40 mm Hg, while exclusion criteria include significant persistent bradycardia, second or third degree AV block, hypotension, and known allergy or intolerance to carvedilol or other beta blockers.",
    "This sample is a phase 1/phase 2 trial for patients with histologically proven adenocarcinoma of the intrathoracic esophagus or gastroesophageal junction, testing the efficacy of pertuzumab and trastuzumab, two drugs, in combination with surgical resection for HER2-positive tumors.",
    "This sample is a phase 1 trial for children and adolescents with type 2 diabetes mellitus, testing the effectiveness of empagliflozin at different doses, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for individuals with HIV infection who have been on antiretroviral therapy for at least 12 months, and it aims to investigate the effects of dipyridamole and placebo on HIV-1 RNA levels. The study has specific inclusion and exclusion criteria, and participants must meet certain laboratory values and have no medical conditions that would prevent their participation.",
    "This sample is a phase 1 clinical trial that aims to evaluate the safety and efficacy of the drug idn-6556 in subjects with hepatic impairment, liver diseases, and digestive system diseases, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with locally advanced or metastatic breast cancer, testing the efficacy of drugs such as everolimus and exemestane, with specific eligibility criteria including positive estrogen-receptor and/or progesterone receptor tumors, negative HER2 status, and previous refractoriness to non-steroidal aromatase inhibitors.",
    "This sample is a phase 1 trial that focuses on patients with HIV-1 infection and hepatitis, using drugs such as sofosbuvir, ribavirin, and ledipasvir/sofosbuvir, and includes eligibility criteria related to HIV and HCV infection, BMI, contraception, and laboratory parameters.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of active ulcerative colitis using the drugs sb012 and placebo, with specific inclusion and exclusion criteria for eligible subjects.",
    "This sample is a phase 1 trial for healthy subjects, testing the drugs palbociclib alone and palbociclib plus itraconazole, with inclusion and exclusion criteria specified.",
    "This sample is a phase 1 clinical trial for patients with advanced renal cell carcinoma, testing the drugs axitinib and mk-3475, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial investigating the use of c1 esterase inhibitor as a treatment for end stage renal disease, kidney failure, delayed graft function, and ischemic reperfusion injury in kidney transplant recipients. The eligibility criteria include age, ABO compatibility, meningococcal vaccination, and specific risk index criteria.",
    "This sample is a phase 1 trial for patients with HIV infection and non-small cell lung cancer, testing the drug erlotinib hydrochloride as a potential treatment option. The eligibility criteria include having known HIV infection, histologically confirmed non-small cell lung cancer, and measurable disease.",
    "This sample is a phase 1 clinical trial for osteoporosis, testing the drugs denosumab 60mg, denosumab 120 mg, and placebo, with eligibility criteria including being of Chinese ancestry, certain liver function levels, and specific age and weight ranges.",
    "This sample is a phase 1 clinical trial testing the drug chlorogenic acid on patients with advanced cancer who have no effective treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the drug rm-131 and placebo in patients with chronic constipation, with specific inclusion and exclusion criteria, and the use of hormonal and barrier methods of birth control for female patients.",
    "This sample is a phase 1 trial for patients with metastatic or unresectable pancreatic cancer, testing the combination of enzalutamide, gemcitabine, and nab-paclitaxel as a potential treatment option. The eligibility criteria include specific disease requirements, prior treatment restrictions, and normal organ function. Exclusion criteria include prior cytotoxic chemotherapy, untreated brain or leptomeningeal metastases, and certain medical conditions.",
    "This sample is a phase 1 clinical trial testing the drug pazopanib in patients with cancer, specifically targeting various types of cancer such as oral cavity, pharynx, and esophagus. The eligibility criteria include being at least 18 years old, having an ECOG performance status of 0-2, and having adequate organ system function. Exclusion criteria include poorly controlled hypertension, history of cardiovascular conditions, gastrointestinal abnormalities, and recent major surgery or trauma.",
    "This sample is a phase 1 trial for previously untreated AML or high-risk MDS patients aged 70 or older, testing the efficacy of omacetaxine and decitabine as potential treatments.",
    "This phase 1 trial is investigating the drug epz-5676 for the treatment of relapsed/refractory acute leukemia patients with rearrangement involving the MLL gene, who are ineligible for other curative treatment regimens.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drugs s-equol and placebo, with inclusion criteria including very mild or mild AD, having a study partner, and speaking English as the primary language, and exclusion criteria including no viable study partner, reporting serious medical risks, and using estrogen replacement therapy.",
    "This sample is a phase 1 clinical trial that aims to evaluate the efficacy of the drug sapanisertib in patients with recurrent glioblastoma or advanced solid tumors, who have exhausted standard treatment options, and have specific disease populations where bevacizumab has shown benefit. The eligibility criteria include having measurable or evaluable disease, specific prior therapy requirements, certain laboratory values, and the ability to swallow whole capsules.",
    "This sample is a phase 1 clinical trial testing the drugs metformin xr, delayed metformin, and sirolimus on patients with metastatic or unresectable solid tumors, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with unspecified adult solid tumors, testing the efficacy of the drug vegfr/pdgfr dual kinase inhibitor x-82 in combination with docetaxel, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with atrial fibrillation, testing the drugs bms-919373, sotalol, and placebo, with specific eligibility and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic or locally advanced refractory/recurrent cancer that expresses MAGE-A3, and it includes eligibility criteria such as prior standard therapy, HLA-A A serotype group positive, age between 18 and 70, and Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1. The study will test the drugs aldesleukin, fludarabine, and cyclophosphamide.",
    "This sample is a phase 1 trial for patients with locally advanced or metastatic pancreatic neoplasms, testing the drugs LY2157299 and gemcitabine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for advanced or metastatic breast cancer, testing the drugs lee011, buparlisib, and letrozole, with eligibility criteria including postmenopausal women who have not received prior therapy for advanced disease and have estrogen-receptor positive and/or progesterone receptor positive breast cancer.",
    "This sample is a phase 1 trial for patients with pancreatic cancer, testing the drugs byl719, gemcitabine, and (nab)-paclitaxel, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with advanced lung cancer and a documented somatic activating mutation in EGFR, testing the efficacy of ruxolitinib and erlotinib in patients who have developed acquired resistance to erlotinib.",
    "This sample is a phase 1 trial for patients with non-Hodgkin lymphoma or advanced and refractory solid tumors, testing the drug copanlisib (bay80-6946) and evaluating eligibility criteria such as histologically confirmed diagnosis, measurable lesions, performance status, and adequate organ functions.",
    "This sample is a phase 1 trial for psoriasis, testing the drug msb0010841 and placebo, with inclusion criteria including chronic plaque psoriasis and specific severity scores, and exclusion criteria including previous treatment with certain interleukin-targeting agents.",
    "This sample is a phase 1/phase 2 clinical trial for patients with chronic lymphocytic leukemia (CLL), testing the effectiveness of the drugs ipi-145, fludarabine, cyclophosphamide, and rituximab, with specific inclusion and exclusion criteria for eligibility.",
    "This phase 1 trial is investigating the use of tolfenamic acid in combination with gemcitabine and radiation therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma, and it includes eligibility criteria such as age \u2265 18 years, ECOG performance status of 0 or 1, and specific laboratory values within normal ranges.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that requires treatment according to the National Cancer Institute (NCI) guidelines. The trial will test the effectiveness of ibrutinib and lenalidomide drugs in treating the diseases, and it has specific eligibility criteria for patients to participate.",
    "This sample is a phase 1 clinical trial for patients with gastrointestinal stromal tumor (GIST) who have failed previous therapies, and it will test the effectiveness of sunitinib and regorafenib as treatment options.",
    "This sample is a phase 1/phase 2 trial for patients with scleroderma or systemic sclerosis, testing the effectiveness of divalproex sodium in treating digital manifestations of the disease, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is investigating the use of temozolomide, a chemotherapy drug, in patients with high grade glioma who have received prior radiation therapy and standard temozolomide, and have either completed chemoradiotherapy or show signs of disease progression.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory B-cell non-Hodgkin lymphoma, testing the effectiveness of bendamustine hydrochloride in combination with 6,8-bis(benzylthio)octanoic acid, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial investigating the drug-drug interaction between avp-786, paroxetine, and duloxetine, and the eligibility criteria include being a healthy adult between 18-50 years old with a BMI of 18-30 kg/m2.",
    "This sample is a phase 1 trial for the treatment of lupus nephritis, testing the drugs ixazomib and placebo, with eligibility criteria including a diagnosis of systemic lupus erythematosus and a kidney biopsy demonstrating specific changes.",
    "This sample is a phase 1 clinical trial for patients with acute myeloid leukemia (AML) who are refractory to prior induction chemotherapy or have relapsed after achieving remission. The study is testing the drug gilteritinib and has specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 trial for healthy Japanese male subjects, testing the drugs telmisartan/amlodipine, telmisartan/amlodipine/hctz, and telmisartan/hctz, with inclusion criteria including age, body weight, body mass index, and signed informed consent, and exclusion criteria including any clinically significant findings or complications.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed and refractory multiple myeloma, testing the drugs selinexor, liposomal doxorubicin, and dexamethasone, with specific eligibility criteria including prior therapies, measurable myeloma paraprotein levels, ECOG performance status, and adequate organ function.",
    "This sample is a phase 1/phase 2 trial for the treatment of gastroparesis using the drugs tc-6499 and placebo, with specific eligibility criteria including a diagnosis of gastroparesis, confirmation using the GEBT, and Type 1 or Type 2 diabetes with controlled blood glucose levels.",
    "This sample is a phase 1 clinical trial for patients with recurrent colorectal carcinoma and other solid neoplasms, testing the drugs cyclosporine and selumetinib, with specific eligibility criteria including prior treatment and progression or intolerance to certain regimens, as well as various health parameters.",
    "This sample is a phase 1 clinical trial for patients with newly-diagnosed glioblastoma multiforme, testing the drug nvx-108 in combination with radiation and temozolomide chemotherapy, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing the drug acy-1215 in combination with pomalidomide and dexamethasone, with specific eligibility criteria including prior treatment requirements and exclusion criteria such as serious medical conditions or prior therapy with certain drugs.",
    "This sample is a phase 1/phase 2 clinical trial for non-small cell lung cancer (NSCLC) patients with specific EGFR activating mutations, testing the drug asp8273, and evaluating eligibility criteria for enrollment.",
    "This sample is a phase 1/phase 2 trial for dry eye disease, testing the drugs dnase and vehicle, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with B cell CLL/SLL leukemia, testing the effectiveness of fludarabine, cyclophosphamide, rituximab, and bendamustine as treatment options for patients who have failed previous standard treatments. The eligibility criteria include age, previous treatment history, hepatic and renal function, cardiac and pulmonary function, and the ability to provide informed consent.",
    "This sample is a phase 1/phase 2 trial testing the drug ibrutinib for the treatment of steroid dependent or refractory classic chronic graft versus host disease (cGVHD). The eligibility criteria include specific disease status, previous treatments, age, and performance status, while exclusion criteria include active acute GVHD, certain concurrent treatments, cardiovascular disease, and other medical conditions.",
    "This sample is a phase 1 clinical trial for patients with recurrent ovarian cancer, testing the drug lde225. The eligibility criteria include having platinum resistant or refractory disease, prior treatment with platinum-based chemotherapy and a taxane, and measurable disease.",
    "This sample is a phase 1 trial for patients with kras and nras wild-type colorectal cancer, testing the combination of regorafenib and panitumumab as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, testing the effectiveness of lenalidomide, ibrutinib, and rituximab as treatment options, with specific eligibility and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with progressive or recurrent glioblastoma multiforme (GBM) who have previously received radiation therapy and temozolomide. The trial will test the efficacy of mibefradil with radiation as a salvage therapy.",
    "This sample is a phase 1 trial for patients with metastatic colorectal cancer or head and neck squamous cell carcinoma, testing the drugs inc280 and cetuximab, with specific eligibility criteria including c-MET positive status and previous treatment with cetuximab or panitumumab.",
    "This sample is a phase 1 trial for pain management, testing the drugs omnitram, tramadol, and placebo, with eligibility criteria including age, vital signs, hematologic and liver function, renal function, and negative tests for substances of abuse and certain diseases.",
    "This sample is a phase 1/phase 2 trial testing the drugs per977, placebo, and enoxaparin on healthy individuals, with inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the safety, tolerability, pharmacokinetics, and pharmacodynamics of the drug MLN3126 in healthy participants, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with hepatocellular carcinoma, testing the use of oral pentamidine as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the drug veliparib (abt-888) on patients with advanced solid tumors, including recurrent high grade serous ovarian cancer and BRCA-mutated breast cancer, who have completed or discontinued platinum-based therapy or prior chemotherapy with anthracycline and/or taxanes. The study aims to assess the safety and efficacy of the drug in these patients.",
    "This sample is a phase 1 clinical trial for subjects with type 2 diabetes, testing the efficacy of semaglutide compared to a placebo, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS), or mixed phenotype acute leukemia (MPAL) who have relapsed or are refractory to chemotherapy, with eligibility criteria including specific organ function requirements, age restrictions, and prior therapy recovery, and exclusion criteria such as certain medical conditions, concurrent use of investigational agents, and prior treatment with selinexor. The study will test the efficacy of selinexor, fludarabine, cytarabine, and methotrexate/hydrocortisone/cytarabine as potential treatments.",
    "This sample is a phase 1 trial testing the drug alisertib in patients with advanced solid tumors and relapsed/refractory lymphoma, with specific eligibility criteria including age, performance status, contraception requirements, and laboratory values.",
    "This sample is a phase 1 clinical trial for the drug \"rdea3170\" in patients with gout, with specific inclusion and exclusion criteria related to body weight, renal impairment, and serum urate levels.",
    "This sample is a phase 1 trial for patients with CD20 positive recurrent or refractory diffuse large B-cell lymphoma, testing the efficacy of carboplatin, etoposide, ibrutinib, and ifosfamide as treatment options, with specific eligibility criteria for patient inclusion.",
    "This sample is a phase 1 clinical trial for patients with estrogen receptor positive and/or progesterone positive breast cancer, testing the drugs alisertib and fulvestrant, with specific eligibility criteria and exclusion criteria.",
    "This sample study is a phase 1/phase 2 trial investigating the effects of the drugs pp1420 and placebo on obesity, with specific eligibility criteria including age, body weight, BMI, and various exclusion criteria such as history of migraine, abnormal eating behavior, and excessive alcohol consumption.",
    "This sample is a phase 1 trial testing the drugs palbociclib alone, palbociclib plus modafinil, and palbociclib plus pioglitazone on healthy subjects, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 clinical trial for patients with progressive and refractory solid malignancies, testing the efficacy of cyclophosphamide pill and imiquimod topical cream in combination with vaccination therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a clinical trial study that focuses on patients with advanced chronic myeloid leukemia (CML) or refractory chronic phase CML, testing the efficacy of MEK-162 and nilotinib drugs in different treatment arms, based on specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial that aims to investigate the effectiveness of ethanol, heparin lock, and normal saline in treating catheter-related bloodstream infections (CRBSI) and bloodstream infections due to central venous catheters or Hickman catheters in patients newly started on home parenteral nutrition with an anticipated duration of more than 3 months. The study has specific inclusion and exclusion criteria, such as patients with non-medicare insurance or medicare insurance with a supplementary insurance, patients with single lumen Hickman catheters, and patients without known alcohol addiction.",
    "This sample is a phase 1/phase 2 trial for patients with diffuse large B-cell lymphoma (DLBCL) or Kaposi sarcoma (KS), testing the drug abc294640. The eligibility criteria include confirmed DLBCL or KS, tumor progression or lack of candidacy for standard therapy, acceptable liver and hematologic function, and willingness to use effective contraception. Exclusion criteria include cardiac disease, pregnancy or nursing, active infections, recent treatment with radiation or chemotherapy, and allergy to radiographic contrast.",
    "This sample is a phase 1 trial for patients with diabetes mellitus, testing the drugs liraglutide and lixisenatide, with inclusion criteria including informed consent, age between 18-65, and a diagnosis of type 2 diabetes, and exclusion criteria including contraindications to GLP-1 mimetics, use of GLP-1 mimetics or DPP-IV inhibitors, and clinically relevant dysglycaemia indicated by HbA1C \u2265 10%.",
    "This sample is a phase 1 clinical trial for patients with metastatic colorectal adenocarcinoma, testing the efficacy of 6,8-bis(benzylthio)octanoic acid and fluorouracil as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for healthy male subjects, testing the drugs pf-06372865, pregabalin, and placebo, with inclusion criteria including age, BMI, and informed consent, and exclusion criteria including various medical conditions and a positive urine drug screen.",
    "This sample is a phase 1 clinical trial for patients with metastatic or locally advanced, unresectable stomach or gastroesophageal cancer, testing the combination of afuresertib and paclitaxel as a second-line treatment option. The eligibility criteria include having received first-line platinum/fluoropyrimidine doublet regimen, having measurable disease, and meeting certain organ system function requirements. The exclusion criteria include history of other malignancies, prior PI3K-AKT-mTOR pathway targeted therapy, unresolved toxicity from prior chemotherapy, and presence of certain medical conditions.",
    "This sample is a phase 1 trial for the drug ro6885247 and placebo in patients with muscular atrophy, spinal, and the eligibility criteria include age, confirmed diagnosis of SMA, ability to provide informed consent, and agreement to contraceptive methods for patients of childbearing potential.",
    "This sample is a phase 1 clinical trial for dry eye disease, testing the efficacy of p-321 ophthalmic solution and its placebo, with inclusion criteria including corneal fluorescein staining score, conjunctival lissamine staining score, and Schirmer test results, and exclusion criteria including anterior segment eye disease and history of glaucoma.",
    "This sample is a phase 1 clinical trial for patients with various B-cell malignancies, including chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma, who have been previously treated and currently require treatment. The drug being tested is idelalisib, and the eligibility criteria include specific disease classifications, previous treatment history, and certain baseline laboratory data.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory classical Hodgkin lymphoma, testing the effectiveness of brentuximab vedotin, etoposide, soludomerin, cisplatin, and ara c as treatment options, with specific eligibility criteria for patient inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial for patients with ovarian carcinoma, testing the drug paclitaxel in combination with NovoTTF-100L(O) System therapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with advanced cancer, testing the drug chlorogenic acid, with eligibility criteria including confirmation of advanced cancer, age between 18 and 65, specific tumor measurements, and baseline organ function requirements.",
    "This sample is a phase 1 trial that includes participants with diabetes and healthy individuals. The trial involves the drugs semaglutide and omeprazole, and the eligibility criteria include age, body mass index, and general health.",
    "This sample is a phase 1 trial for patients with pleural effusion in breast carcinoma, testing the use of bevacizumab for pleural implantable device, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial investigating the drug MLN9708 in patients undergoing allogeneic hematopoietic stem cell transplantation, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with recurrent glioma, testing the effectiveness of carboplatin-based chemotherapy on tumors less than 35 mm in diameter, with various eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with chronic myeloid leukemia, testing the effectiveness of nilotinib and ruxolitinib drugs, with specific eligibility criteria including organ function, electrolyte values, pregnancy status, and laboratory values.",
    "This sample is a phase 1 trial for healthy volunteers, testing the drug \"bi 1181181\" in both young and elderly subjects, with specific inclusion and exclusion criteria related to medical history, physical examination, vital signs, laboratory tests, and concomitant diseases.",
    "This sample is a phase 1 clinical trial for patients with acute myeloid leukemia (AML) in complete remission, testing the combination of lenalidomide and cytarabine as a treatment option, with specific eligibility criteria for both recipients and donors.",
    "This sample is a phase 1 clinical trial for patients with recurrent, progressive, or refractory central nervous system tumors, specifically focusing on those with retinoblastoma protein (Rb1) positive tumors, and the drug being tested is palbociclib isethionate.",
    "This sample is a phase 1/phase 2 clinical trial for idiopathic pulmonary fibrosis (IPF) patients, testing the efficacy of inhaled td139 compared to a placebo, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for asthma patients, testing the effectiveness of ot329 (combination of fluticasone propionate and salmeterol xinafoate) and advair diskus (combination of fluticasone propionate and salmeterol xinafoate) compared to a placebo, with eligibility criteria including age, asthma history, lung function, smoking history, and medication usage.",
    "This sample is a phase 1 trial for the drug gsk2256294 and placebo in patients with chronic obstructive pulmonary disease, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase I clinical trial for tobacco use disorder, testing the effectiveness of levomilnacipran and placebo in helping individuals quit smoking, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis. The trial aims to evaluate the effectiveness of inhaled nitric oxide at different doses in treating these diseases. The eligibility criteria include specific diagnostic criteria, smoking history, age range, and other medical conditions that may affect the suitability of the subjects for the study.",
    "This sample is a phase 1 clinical trial for patients with locally advanced unresectable or metastatic pancreatic adenocarcinoma and cholestatic hyperbilirubinemia due to bile duct obstruction. The trial will test the effectiveness of nab-paclitaxel and gemcitabine as treatment options.",
    "This sample is a phase 1 trial testing the drugs tgr-1202 and ibrutinib on patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for patients with mantle cell lymphoma, testing the effectiveness of ibrutinib and carfilzomib as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for allergic rhinitis, testing the drugs hollisterstier and normal saline, with inclusion criteria including a positive skin prick test or serum specific IgE level for house dust mite, cat, or dog allergies, and exclusion criteria including uncontrolled or severe asthma, low compliance, and administration of certain medications within the last 2 weeks.",
    "This phase 1 trial is investigating the use of gemcitabine hydrochloride in patients with recurrent ovarian epithelial cancer, recurrent fallopian tube carcinoma, or recurrent primary peritoneal carcinoma who have experienced recurrence or progression within 12 months after completion of platinum-based chemotherapy.",
    "This sample is a phase 1 trial for HIV-1 infection, testing the drugs bictegravir and placebo, with specific eligibility criteria including no prior anti-HIV treatment, certain HIV-1 RNA levels, and CD4+ cell count.",
    "This sample is a clinical trial study that focuses on three different cohorts: Cohort A for Soft Tissue Sarcoma with metastasis limited to lung, Cohort B for Myxoid Liposarcoma, and Cohort C for Retroperitoneum Sarcoma. The study aims to evaluate the effectiveness of trabectedin as a treatment option for these specific types of sarcoma.",
    "This sample is a phase 1/phase 2 clinical trial for patients with unresectable or metastatic malignant melanoma, testing the drug ipilimumab, with inclusion criteria including confirmed diagnosis of melanoma, prior adjuvant therapy, ECOG performance status of 0 or 1, and adequate hematologic, renal, and hepatic function, while exclusion criteria include autoimmune diseases, active brain metastasis, uncontrolled infectious diseases, pregnancy, breastfeeding, and hypersensitivity to the study drug or its components.",
    "This sample is a phase 1 clinical trial for patients with squamous cell carcinoma of the head and neck, testing the efficacy of ficlatuzumab and cetuximab as a treatment option. The eligibility criteria include having histologically confirmed HNSCC, being cetuximab-resistant, and having an Eastern Cooperative Oncology Group Performance Status of 0-1.",
    "This sample is a phase 1 trial for patients with locally advanced pancreatic cancer, testing the combination of nab-paclitaxel and gemcitabine as chemoradiotherapy treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with chronic Hepatitis B infection, testing the efficacy of antiviral therapy (tenofovir or entecavir) and birinapant compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for hepatocellular cancer, testing the drug sorafenib, with eligibility criteria including histologically confirmed HCC, Barcelona Clinic Liver Cancer Stage B or C, and no evidence of cirrhosis or cirrhosis grade of Child-Pugh class A or B7.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed and/or refractory multiple myeloma, testing the drugs mk-3475, pomalidomide, and dexamethasone, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs gsk2838232, placebo, and ritonavir for the treatment of infection with human immunodeficiency virus (HIV), with inclusion criteria including age between 18 and 55, good health, and specific laboratory values, and exclusion criteria including liver disease, asthma, and cardiac arrhythmias.",
    "This sample is a phase 1 trial for a respiratory syncytial virus (RSV) vaccine called medi8897, with eligibility criteria including healthy infants born between 32 and 34 weeks gestational age who are entering their first RSV season, and exclusion criteria such as prior RSV infection or receipt of palivizumab or any RSV vaccine.",
    "This sample is a phase 1/phase 2 trial for patients with primary liver tumors, specifically hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and other primary tumors not larger than 7 cm, who are not eligible for standard treatment options. The trial will test the effectiveness of bleomycin phc 15 e. in electrochemotherapy as a therapeutic option.",
    "This sample is a phase 1 trial for patients with hepatocellular cancer (HCC) that is not amenable to surgical resection, testing the drugs trametinib and sorafenib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with ALK-positive advanced non-small cell lung cancer, testing the drugs ribociclib and ceritinib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS), testing the drug bvd-523. The eligibility criteria include having received at least one prior therapy, having an ECOG performance status of 0 to 2, and adequate liver, renal, and cardiac function. Exclusion criteria include concomitant malignancies, gastrointestinal conditions impairing absorption of the study medication, and uncontrolled or severe intercurrent medical conditions.",
    "This sample is a phase 1 clinical trial for a drug called ak0529 and a placebo, testing their safety and efficacy in healthy individuals aged 18 to 55 years with a BMI of 18.0 to 31.0 kg/m2, and includes detailed inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with non-small cell lung cancer (NSCLC) and ALK-positive tumors, testing the drug ceritinib as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory acute myeloid leukemia, testing the effectiveness of mitoxantrone hydrochloride, etoposide, cytarabine, and selinexor as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with non-small-cell lung carcinoma, testing the drugs nintedanib and docetaxel, with specific eligibility criteria including age, disease subtype, prior treatments, and performance status.",
    "This sample is a phase 1 clinical trial for patients with bladder cancer, transitional cell carcinoma, renal pelvis cancer, ureter cancer, or urethra cancer. The trial will test the effectiveness of enzalutamide, cisplatin, and gemcitabine in treating these diseases. The eligibility criteria include confirmed evidence of the specified cancers, stage IV disease, and normal organ and marrow function.",
    "This sample is a phase 1/phase 2 trial investigating the use of curcumin and mouthwash in treating grade 2 oral mucositis related to chemotherapy for cancer, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug tas-102 on patients with advanced solid tumors, excluding breast cancer, who meet certain eligibility criteria.",
    "This sample is a phase 1 clinical trial for patients with recurrent ovarian cancer, testing the combination of nuc-1031 and carboplatin as a potential treatment option. The eligibility criteria include having a relapse within 24 months of platinum-based chemotherapy, being at least 18 years old, and having measurable or evaluable disease. The study also specifies various requirements for bone marrow, liver, and renal function, as well as contraception for participants of child-bearing potential. Exclusion criteria include previous gemcitabine or Nuc-1031 treatment, allergic reactions to carboplatin, and certain medical conditions or infections.",
    "This sample is a phase 1/phase 2 clinical trial for patients with leukemia, specifically newly diagnosed acute myeloid leukemia (AML), who are not eligible for stem cell transplantation. The trial involves the drugs bms-936564 and cytarabine, and has specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for patients with acute myeloid leukemia (AML) and includes the drugs gmi-1271, mitoxantrone, etoposide, cytarabine, and idarubicin as part of the treatment regimen. The eligibility criteria include specific age requirements, prior treatment history, and organ function.",
    "This sample is a phase 1 clinical trial testing the drug ibrutinib on patients with relapsed and refractory T-cell lymphoma, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with myelodysplastic syndrome or acute myeloid leukemia, testing the drugs lenalidomide and velcade, with eligibility criteria including prior allogeneic SCT, age 18 or older, and specific organ function requirements.",
    "This sample is a phase 1 trial for patients with advanced stage epithelial ovarian cancer, testing the combination of metformin, carboplatin, and paclitaxel as chemotherapy treatment, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of diabetic macular edema and age-related macular degeneration using the drug mtp-131, with specific eligibility criteria for each disease group.",
    "This sample is a phase 1/phase 2 trial testing a placebo drug on healthy participants, with specific inclusion and exclusion criteria related to medical history, infections, surgeries, heart conditions, and adverse reactions to vaccines or vaccine products.",
    "This sample is a phase 1/phase 2 trial testing the drug decitabine in patients with colorectal cancer and liver metastasis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for patients with gastric carcinoma, testing the drug combination of oxaliplatin and s-1, with specific eligibility criteria including disease characteristics, age, tumor sample availability, and adequate organ function.",
    "This sample is a phase 1 clinical trial for patients with hepatocellular carcinoma, testing the drugs cc-122 and sorafenib, and includes eligibility criteria such as confirmed diagnosis, stage of cancer, measurable lesions, and specific laboratory parameters.",
    "This sample is a phase 1/phase 2 trial for the treatment of seizures using cannabidiol oral solution, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for head and neck cancer, testing the combination of metformin and cisplatin as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs ibrutinib and nivolumab for the treatment of hematologic neoplasms, specifically B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, B-cell follicular lymphoma, and histologically-confirmed diffuse large B-cell lymphoma, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for subjects with schizophrenia, testing the drugs pf-04958242 and placebo. The eligibility criteria include being psychiatrically stable, having a BMI within a specific range, and having a DSM-IV diagnosis of schizophrenia.",
    "This sample is a phase 1 clinical trial for the treatment of b-cell chronic lymphocytic leukemia, testing the drugs chlorambucil, obinutuzumab, placebo, and tocilizumab, with specific eligibility criteria for participants.",
    "This sample is a phase 1 clinical trial for the treatment of osteoarthritis in the knee using the drugs neo6860 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with castration-resistant prostate cancer, testing the drugs enzalutamide and metformin hydrochloride, with eligibility criteria including measurable disease, castrate levels of testosterone, and certain laboratory values within normal limits.",
    "This sample is a phase 1 trial for chronic hepatitis C, testing the drugs al-335 matching placebo and al-335, with eligibility criteria including age, BMI, and documentation of genotype 1 HCV infection for greater than 6 months.",
    "This sample is a phase 1 trial for patients with melanoma, testing the combination of pembrolizumab and high dose interferon alfa-2b (hdi) as neoadjuvant treatment, with specific eligibility criteria including disease stage, nodal involvement, and surgical resectability.",
    "This sample is a clinical trial study that aims to evaluate the effectiveness of c-met inhibitor amg 337, oxaliplatin, leucovorin calcium, and fluorouracil in treating various gastrointestinal cancers, including adenocarcinoma of the esophagus, adenocarcinoma of the gastroesophageal junction, and diffuse adenocarcinoma of the stomach. The study includes specific eligibility criteria for patients, such as having a life expectancy of at least 12 weeks, specific blood count levels, and not having certain medical conditions.",
    "This sample is a phase 1/phase 2 trial for systemic scleroderma, testing the effectiveness of c-82 topical gel (1% and placebo) in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for heart failure patients who have been on oral furosemide or therapeutic equivalent for 90 days, testing the efficacy of furosemide injection solution and oral furosemide tablets in reducing symptoms of chronic fluid overload.",
    "This sample is a phase 1/phase 2 clinical trial for patients with recurrent platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer, testing the effectiveness of niraparib and bevacizumab as treatment options. The eligibility criteria include having high-grade serious or high-grade endometrioid histology, prior platinum-containing therapy, and fulfilling various organ function and medical history requirements.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic melanoma, testing the effectiveness of vemurafenib, lymphodepleting chemotherapy, til infusion, and interleukin-2 as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drug \"gsk1265744 30 mg\" on subjects with severe renal impairment and healthy control subjects, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs placebo and myk-461 on healthy individuals, with inclusion criteria including normal BMI, LVEF, and ECG, and exclusion criteria including any structural abnormalities on echocardiography and positive HIV or HCV/HBV results.",
    "This sample is a phase 1 trial for patients with metastatic or locally advanced and unresectable gastric or gastroesophageal junction adenocarcinoma, testing the efficacy of ramucirumab, capecitabine, cisplatin, s-1, and oxaliplatin as first-line systemic chemotherapy.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drugs jnj-54861911 and placebo, with inclusion criteria including normal cognitive rating and evidence of amyloid deposition, and exclusion criteria including other brain diseases and contra-indications for MRI.",
    "This sample is a phase 1 trial for Japanese males with metastatic castration-resistant prostate cancer, testing the drug bay 1841788 (odm-201) to evaluate its efficacy and safety.",
    "This sample is a phase 1 trial for the drug gs-6615 and dofetilide in patients with long qt syndrome, with specific inclusion and exclusion criteria related to cardiovascular health and medical history.",
    "This sample is a phase 1 clinical trial for the drug ged-0301 in patients with Crohn's Disease, with specific inclusion and exclusion criteria, and various laboratory and medical condition requirements.",
    "This sample is a phase I trial for pain management in patients scheduled for primary total knee arthroplasty, using drugs such as exparel, ropivacaine cocktail, and bupivacaine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with cardiovascular disease, testing the use of aspirin and durlaza\u2122 in individuals with Type 2 Diabetes and a history of coronary artery disease, peripheral vascular disease, or ischemic stroke, along with at least 2 cardiovascular disease risk factors.",
    "This sample is a phase 1 trial testing the drug lenalidomide in patients with high-risk CD34+ AML or MDS who have undergone allogeneic transplant, and the eligibility criteria include age, disease status, cytogenetics, performance status, blood counts, liver and kidney function, and participation in the Revlimid REMS\u00ae program.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or relapsed and refractory multiple myeloma, testing the efficacy of vlx1570 and dexamethasone as a treatment option. The eligibility criteria include having received at least 2 prior therapies, measurable disease, certain kidney function, age, performance status, and contraception requirements. Exclusion criteria include concurrent treatments, recent cytotoxic or biologic therapy, pregnancy or breastfeeding, uncontrolled hypertension or diabetes, active hepatitis B or C infection or HIV infection, significant cardiovascular disease, prolonged QT/QTc interval, history of torsade de points or other risk factors, concomitant medications that prolong QT/QTc interval, uncontrolled intercurrent illness, active infection, recent major surgery, use of investigational agents, history of other malignancy, intolerance to steroids or H1/H2-antagonists, elevated serum calcium level, diagnosed with plasma cell leukemia, POEMS syndrome or amyloidosis, and history of CNS myeloma or other CNS malignancy.",
    "This sample is a phase 1 trial for idiopathic Parkinson's disease, testing the drugs pf-06649751 and trimethobenzamide hydrochloride, along with a placebo, on patients who are L-DOPA-responsive and experiencing motor fluctuations.",
    "This sample is a phase 1 trial for the treatment of hypercholesterolemia, testing the drugs cat-2054, placebo, cat-2054-c, and atorvastatin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for seasonal allergic rhinitis, testing the effectiveness of nasapaque nasal solution and placebo saline nasal solution, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic melanoma, testing the effectiveness of cyclophosphamide, fludarabine, interleukin-2, and peginterferon alfa-2b as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for HER-2 negative breast cancer patients, testing the drugs BYL719 and nab-paclitaxel, with eligibility criteria including measurable disease, prior chemotherapy, ECOG performance status, and specific laboratory values.",
    "This sample is a phase 1/phase 2 clinical trial for atopic dermatitis, testing the efficacy of am1030-cream or placebo on AD lesions located on the trunk and/or limbs, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs ibrutinib, erythromycin, and voriconazole on patients with b-cell chronic lymphocytic leukemia who have relapsed or refractory disease after prior systemic therapy, and meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial for non-small cell lung cancer patients who are not eligible for surgery or radiation therapy, and it involves the drugs carboplatin, nab-paclitaxel, and mk-3475. The eligibility criteria include having measurable disease, ECOG performance status of 0-1, and archival tissue availability for research testing.",
    "This sample is a phase 1 trial testing the drug rolapitant for the treatment of chemotherapy-induced nausea and vomiting, with specific eligibility criteria for subjects including age, BMI, and previous drug exposure.",
    "This sample is a phase 1 clinical trial for patients with muscular dystrophy, specifically Duchenne. The trial is testing the safety and efficacy of the drug SMT C1100, and the eligibility criteria include being male, between 5 and 13 years old, and having a genetic diagnosis of DMD. The study also requires adherence to a balanced diet and prohibits sexual intercourse during the treatment phases.",
    "This sample is a phase 1 clinical trial for post-menopausal patients with metastatic or locally advanced breast cancer, testing the efficacy of fulvestrant and mln9708 as endocrine therapy options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for participants with melanoma, testing the drug ipilimumab. The trial includes three cohorts based on disease stage, and participants must meet specific eligibility criteria.",
    "This sample is a phase 1 trial for patients with congestive heart failure, testing the drug mtp-131 and placebo, with specific eligibility criteria including LVEF \u226435% and stable HF for at least 6 months.",
    "This sample is a phase 1 clinical trial for patients with advanced solid tumors and breast cancer, testing the efficacy of palbociclib + taselisib/pictilisib, targeting PI3K-AKT pathway mutations, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase I trial for patients with newly diagnosed lymphoma, where the drugs pegfilgrastim and loratadine are being used in combination with chemotherapy to minimize the risk of neutropenic fever. The eligibility criteria include specific lymphoma types, planned chemotherapy regimen, age, performance status, and ability to provide informed consent. Exclusion criteria include chronic bone pain, low creatinine clearance, allergies to certain medications, chronic antihistamine usage, inability to swallow medications, and inability to complete survey accurately.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-small cell lung cancer (NSCLC) who have failed prior chemotherapy regimens. The study aims to evaluate the efficacy of docetaxel and tak-117 drugs in treating NSCLC patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with colon and rectal adenocarcinoma, testing the drugs capecitabine and nintedanib, with specific eligibility criteria including prior treatment history and various medical parameters.",
    "This sample is a phase 1 trial for patients with soft tissue sarcoma or bone tumor, testing the effectiveness of trabectedin and olaparib drugs, with specific eligibility criteria including organ function, age, and exclusion criteria such as previous enrollment in the study or severe medical conditions.",
    "This sample is a phase 1 trial testing the drugs nvr 3-778, placebo for nvr 3-778, and pegasys for the treatment of chronic hepatitis B, specifically in patients who are HBeAg positive and have no history of clinical decompensation.",
    "This sample is a phase 1/phase 2 trial that aims to evaluate the effectiveness of ibrutinib and durvalumab in treating non-small cell lung cancer, breast cancer, and pancreatic cancer patients who have relapsed or refractory disease and meet specific eligibility criteria.",
    "This sample is a phase 1 trial for hypoglycemia, testing the drugs biod-961, lilly glucagon, and novo glucagon, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for asthma, testing the effectiveness of various fluticasone/formoterol drugs, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with metastatic renal cell carcinoma, testing the drugs pazopanib, sorafenib, and radium-223, with eligibility criteria including age \u2265 18 years, documented diagnosis of RCC, presence of at least one metastatic bone lesion, ECOG performance status of 0-2, and adequate organ and bone marrow function. Exclusion criteria include prior therapy with sorafenib, prior therapy with radium-223 or systemic radiotherapy, and known brain metastases or cranial epidural disease.",
    "This phase 1 trial is investigating the use of drugs rg7388 and pegasys in patients with polycythemia vera and essential thrombocythemia who have previously been treated with other agents and are either intolerant or resistant, and have high risk or low risk disease with symptoms.",
    "This sample is a phase I clinical trial for women with suspected ovarian cancer, testing the effectiveness of fermented wheat germ extract (fwge) compared to a placebo, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for the treatment of type 2 diabetes mellitus, testing the drugs sar425899 and metformin, along with a placebo, in healthy subjects and patients with T2DM who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for individuals with autism spectrum disorder (ASD) to test the effects of intranasal oxytocin and placebo on their symptoms, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with unipolar major depressive disorder, testing the effectiveness of ketamine and midazolam drugs in combination with electroconvulsive therapy (ETC) for treatment.",
    "This sample is a phase 1 clinical trial for patients with advanced cancer, specifically breast cancer, ovarian cancer, and other advanced cancers, testing the combination therapy of carboplatin and olaparib, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with HER2 positive metastatic breast cancer, testing the drugs pyrotinib, lapatinib, and capecitabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with advanced non-small-cell lung carcinoma, testing the combination of the drugs mk-3475 and gemcitabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for melanoma patients, testing the drugs montanide isa-51, polyiclc, and cyclophosphamide, with specific eligibility criteria including disease stage, radiological studies, brain metastases, laboratory parameters, and age.",
    "This sample is a phase 1 clinical trial for patients with recurrent and/or metastatic head and neck squamous cell carcinoma, testing the drug lee011, with eligibility criteria including previous treatment with anti-EGFR therapy, measurable disease, and ECOG performance status 0-1.",
    "This sample is a phase 1 trial for patients with hormone-resistant prostate cancer and metastatic malignant neoplasm in the bone, testing the drugs fludeoxyglucose f-18 and fluorine f 18 sodium fluoride for imaging procedures, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for healthy male volunteers, testing the effects of nestorone\u00ae/testosterone gel and testosterone only gel on sperm concentration, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for the drug dalazatide and placebo in adult subjects with plaque psoriasis, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for Parkinson's disease, testing the drug irx4204, with inclusion criteria including age range, clinical diagnosis of PD, and stable dose of PD symptomatic therapy, and exclusion criteria including other forms of parkinsonism, motor fluctuations, dementia, and various medical and psychiatric illnesses.",
    "This sample is a phase 1 clinical trial for the treatment of thrombosis, using drugs such as BMS-986120, aspirin, and clopidogrel, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for patients with muscular dystrophy, specifically Duchenne muscular dystrophy, testing the drugs edasalonexent and placebo. The inclusion criteria include a diagnosis of DMD, ability to walk independently, and adequate immunization for influenza and varicella. Exclusion criteria include recent use of corticosteroids, other significant medical conditions, and exposure to other investigational drugs. Patients who participated in Part A must meet additional criteria to participate in Part B, and there are no entry criteria for Part C.",
    "This sample is a phase 1 trial for patients with advanced, recurrent, and progressive solid tumors or cancer, testing the drug cripec\u00ae docetaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase I clinical trial for patients with head and neck cancer, pancreatic cancer, and depression, testing the use of ketamine as a potential treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with ulcerative colitis, testing the effectiveness of a herbal treatment (sa100) for those who are refractory to or intolerant of 5-aminosalicylic acid (5-ASA) and have active mucosal disease.",
    "This sample is a phase 1 trial for patients with various hematologic malignancies, including acute myelogenous leukemia, acute lymphocytic leukemia, and myelodysplastic syndrome, who will receive a conditioning regimen followed by a haploidentical stem cell transplant from a related donor. The eligibility criteria include specific disease characteristics, organ function requirements, and the absence of alternative matched donors. The study will assess the safety and efficacy of the treatment regimen.",
    "This sample is a phase I clinical trial for prostate cancer patients with intermediate to high-risk disease, testing the drug pyruvate, and includes eligibility criteria such as biopsy-proven adenocarcinoma, specific laboratory criteria, and the use of contraception during and after the study.",
    "This sample is a phase 1 clinical trial for the treatment of non-alcoholic fatty liver disease (NAFLD) using metformin, with specific inclusion and exclusion criteria outlined.",
    "This phase 1 trial is testing the drug biib054 and a placebo in patients with Parkinson's disease and healthy individuals, with specific inclusion and exclusion criteria related to health, contraception, body mass index, and medical history.",
    "This sample is a phase 1 trial that focuses on hypoglycemia in patients with type-1 diabetes, testing the effectiveness of glucagon (zp-glucagon) and glucagon (glucagen) as potential treatments. The eligibility criteria include age, duration of diabetes, insulin treatment, and glycated hemoglobin levels. Exclusion criteria include a history of hypoglycemic coma or seizures, recent severe hypoglycemia, and certain medical conditions.",
    "This sample is a phase 1 clinical trial for patients with unresectable or metastatic pancreatic cancer, testing the drug cyclophosphamide, and includes eligibility criteria such as prior chemotherapy, age, performance status, and organ function.",
    "This sample is a phase 1/phase 2 trial for patients with advanced classical Hodgkin Lymphoma, testing the drug adcetris-levact. The eligibility criteria include age 60-80, specific disease stage, and various organ function requirements.",
    "This sample is a phase 1 trial for non-small cell lung cancer patients with EGFR mutation and cMET amplification, testing the efficacy of inc280 single agent and erlotinib as treatment options.",
    "This sample is a phase 1/phase 2 trial for systemic lupus erythematosus, testing the drugs matching placebo and cenerimod, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for HIV-positive individuals on a stable raltegravir-containing antiretroviral regimen, testing the safety and efficacy of raltegravir 1200 mg in combination with tums and leader antacid, with specific inclusion and exclusion criteria.",
    "This phase 1 trial is investigating the use of the drugs jnj-42847922, diphenhydramine, and placebo in the treatment of major depressive disorder, with specific eligibility criteria including BMI between 18 and 30 kg/m2, meeting diagnostic criteria for MDD, and limitations on previous antidepressant treatments.",
    "This sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma who are non-responsive to or ineligible for autologous stem cell transplant, and who progress after prior exposure to proteasome inhibitor and lenalidomide or pomalidomide or thalidomide. The study aims to evaluate the efficacy and safety of mln9708, dexamethasone, and bendamustine in treating these patients.",
    "This sample is a phase 1 clinical trial for patients with metastatic prostate cancer, testing the efficacy of burixafor hydrobromide, docetaxel, and g-csf as chemotherapy drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with rheumatoid arthritis, testing the drug Enbrel (t0001), with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 trial for patients with advanced relapsed or refractory solid tumors, testing the drugs omp-131r10 and folfiri, with eligibility criteria including confirmed histology, age \u226518, ECOG performance status 0 or 1, evaluable disease per RECIST 1.1, availability of FFPE tissue, and specific laboratory values within normal ranges.",
    "This sample is a phase 1 clinical trial for ovarian cancer, testing the drugs veliparib, carboplatin, and paclitaxel, with specific eligibility criteria for participants.",
    "This sample is a phase 1 trial for women with ER+/PR+ HER2-negative breast cancer, testing the use of rosuvastatin as an endocrine therapy option, with eligibility criteria including intact breast tumor size of at least 1cm, post-menopausal status, and normal laboratory criteria.",
    "This sample is a phase 1/phase 2 trial for macular edema, testing the drug dexamethasone phosphate ophthalmic. The eligibility criteria include having a mean central subfield thickness (CST) of at least 300\u00b5m on SD-OCT images for conditions such as retinal vein occlusion or diabetic macular edema.",
    "This sample is a phase 1 trial for patients with hematologic malignancies, including acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic myeloid leukemia (CML), MDS, Hodgkin lymphoma, and Non-Hodgkin lymphoma (NHL), who are eligible for allogeneic stem cell transplantation and lack a suitable conventional donor. The drug being tested is ap1903, and the inclusion criteria include age between 18 and 65, high-resolution HLA typing, and adequate organ function. Exclusion criteria include prior allogeneic transplantation, active CNS involvement by malignant cells, and current uncontrolled infections.",
    "This sample is a phase 1 trial for patients with renal cell cancer, testing the drugs avelumab and axitinib, and includes eligibility criteria such as having a resected primary tumor and measurable lesions as defined by RECIST version 1.1.",
    "This sample is a phase 1/phase 2 clinical trial for non-small-cell lung cancer patients with EGFR activating mutations, testing the drugs gilteritinib and erlotinib, and includes eligibility criteria such as prior treatment with an EGFR tyrosine kinase inhibitor and adequate organ function.",
    "This sample is a phase 1 trial for participants with symptomatic multiple myeloma, testing the drugs daratumumab, bortezomib, and dexamethasone, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for small cell lung cancer (SCLC) patients, testing the efficacy of carboplatin, placebo, trilaciclib, and etoposide as potential treatments. The eligibility criteria include age, confirmed SCLC diagnosis, target lesion presence, ECOG performance status, and adequate organ function. Exclusion criteria include prior chemotherapy for extensive-stage SCLC, symptomatic brain metastases, uncontrolled heart disease, recent stroke, and other serious chronic diseases.",
    "This sample is a phase 1 trial for HIV-infected pregnant females, testing the efficacy of different drug combinations (efavirenz, tenofovir/emtricitabine, tenofovir/lamivudine, lamivudine/zidovudine) in maintaining viral load suppression and CD4 count above 100 cells/mm3, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for type 1 diabetes mellitus, testing the effects of pramlintide acetate, placebo, lispro insulin u-100, and regular insulin u-100 on subjects who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a clinical trial for children with autism and gastrointestinal problems, testing the effectiveness of oral vancomycin, moviprep, and prilosec in improving their symptoms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with head and neck squamous cell carcinoma, testing the drugs cisplatin, docetaxel, and wee1 inhibitor azd1775, with eligibility criteria including specific tumor characteristics and overall health requirements.",
    "This sample is a phase 1 trial for patients with myelodysplastic syndromes (MDS) testing the combination of atezolizumab and azacitidine as a treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for pregnancy, testing the drugs menopur and endometrin, with specific eligibility criteria including age, BMI, hormone levels, fallopian tube and uterine health, and excluding factors such as male infertility, systemic diseases, recent pregnancy, prior gonadotropin treatment, ovarian cysts, endometriosis, uterine fibroids, substance abuse, history of chemotherapy or radiotherapy, and minors or those unable to consent.",
    "This sample is a phase 1 trial for patients with glioblastoma multiforme and astrocytoma, grade IV, testing the drugs poly-iclc and temozolomide, with inclusion criteria including newly diagnosed patients, genome sequencing consent, and normal organ function, and exclusion criteria including prior immunotherapy, inadequate tissue acquisition, and pre-existing immunodeficiency disorders.",
    "This sample is a phase 1/phase 2 clinical trial for small cell lung cancer (SCLC) patients, testing the efficacy of trilaciclib and topotecan drugs in combination with placebos, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1/phase 2 trial for muscular dystrophy (DMD) patients, testing the drugs ro7239361 and placebo, with inclusion criteria including being diagnosed with DMD, able to walk without assistance, able to walk up 4 stairs in 8 seconds or less, weighing at least 15 kg, and taking corticosteroids for DMD, and exclusion criteria including ejection fraction < 55% on echocardiogram, any behavior or mental issue affecting study procedures, previous or current use of medications like androgens or human growth hormone, use of a ventilator during the day, inability to have blood samples collected or receive an injection under the skin, treatment with exon skipping therapies 6 months prior to study start, and treatment with ataluren or any investigational drug currently or within 5 half-lives prior to study start.",
    "This sample is a phase 1 clinical trial for participants with multiple myeloma, testing the efficacy of daratumumab and recombinant human hyaluronidase as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with type 1 diabetes mellitus, testing the effectiveness of biochaperone insulin lispro and humalog\u00ae in reducing insulin dosage and improving glycemic control.",
    "This phase 1 trial is investigating the use of nivolumab, an immune checkpoint inhibitor, in patients with recurrent malignant glioma, astrocytoma, or glioblastoma who have not been previously treated with bevacizumab. The study includes eligibility criteria such as age, performance status, prior radiation therapy, and laboratory values, while excluding patients with certain medical conditions or previous treatments.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed/refractory acute myeloid leukemia (AML) who have FLT3-ITD and/or FLT3-D835 mutations. The study aims to evaluate the efficacy and safety of selinexor and sorafenib as potential treatments for these patients. The eligibility criteria include age, performance status, hepatic and renal function, and previous exposure to FLT3 inhibitors. The exclusion criteria include allergies to the study drugs, concurrent medical conditions, and unstable cardiovascular function.",
    "This sample is a phase 1 trial for patients with castration-resistant prostate carcinoma, testing the drugs enzalutamide and niclosamide, with specific eligibility criteria including confirmed rising PSA and castrate serum testosterone levels.",
    "This sample is a phase 1/phase 2 trial for the drug qr-010 and placebo in patients with cystic fibrosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the effectiveness of ranpirnase and a vehicle in treating condylomata acuminata, papillomavirus infections, and sexually transmitted diseases, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for functional constipation, testing the effectiveness of various drugs including yh12852, prucalopride, and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a clinical trial for patients with head and neck squamous cell carcinoma, testing the drug vorinostat in phase I/II, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for healthy individuals, testing the drugs ixekizumab, boostrix\u00ae, and pneumovax\u00ae23, with eligibility criteria including BMI range and exclusion criteria such as previous participation in similar studies and allergies to certain therapies or vaccines.",
    "This sample is a phase 1 trial for rheumatoid arthritis, testing the drugs meriva and placebo, with eligibility criteria including a diagnosis of RA, active disease, and willingness to sign informed consent.",
    "This sample is a phase 1 trial for patients with cutaneous T-cell non-Hodgkin lymphoma, recurrent mycosis fungoides and sezary syndrome, and stage II-IV mycosis fungoides and sezary syndrome. The trial aims to evaluate the effectiveness of fludarabine, cyclophosphamide, mycophenolate mofetil, and tacrolimus in patients who have failed standard therapy or are not eligible for it. Eligibility criteria include specific disease stage, responsive skin disease, related donor with HLA mismatch, adequate organ function, performance status, and absence of certain conditions.",
    "This sample is a phase 1/phase 2 trial for type 2 diabetes mellitus, testing the drug medi0382 against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for healthy individuals, testing the effects of clonidine on various parameters, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug 5-fu for the treatment of low risk nodular basal cell carcinoma and other skin tumors, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with rectal cancer, testing the drugs byl719 and capecitabine, with eligibility criteria including histologically proven adenocarcinoma of the rectum, no evidence of distant metastases, and specific laboratory values within normal range.",
    "This sample is a phase 1 trial for patients with non-small cell lung cancer or malignant pleural mesothelioma, testing the drug vinorelbine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for psoriasis patients, testing the drugs vtp-43742, placebo 1, and placebo 2, with inclusion criteria including a confirmed diagnosis of chronic plaque-type psoriasis and exclusion criteria including a history of treatment with biologicals within 6 months of the study.",
    "This sample is a phase 1 clinical trial for patients with relapsed or refractory solid tumors or desmoid fibromatosis, testing the use of doxorubicin hcl liposomal injection as a potential treatment option.",
    "This sample is a phase 1/phase 2 trial for patients with various types of peripheral T-cell lymphoma, testing the effectiveness of a combination of drugs including cyclophosphamide, doxorubicin hydrochloride, etoposide, lenalidomide, prednisone, and vincristine sulfate, with specific eligibility criteria for patient inclusion.",
    "This sample is a phase 1 trial for patients with type 1 diabetes mellitus, testing the effectiveness of biochaperone insulin lispro and humalog\u00ae in managing blood glucose levels, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with type 2 diabetes mellitus, testing the effectiveness of biochaperone insulin lispro and humalog\u00ae in patients who have been treated with stable multiple daily insulin for at least 3 months. The inclusion criteria include having a BMI below or equal to 40.0 kg/m\u00b2 and an HbA1c level of \u2264 9.0%. The exclusion criteria include known hypersensitivity to trial products, type 1 diabetes mellitus, previous participation in this trial, and the receipt of any investigational product within 60 days prior to this trial. Other exclusion criteria include clinically significant abnormal screening tests, presence of acute gastrointestinal symptoms, renal impairment, late diabetic complications and/or acute coronary heart disease, known slowing of gastric emptying and/or gastrointestinal surgery, unusual meal habits and special diet requirements, and current treatment with corticosteroids.",
    "This sample is a phase 1 clinical trial for idiopathic Parkinson's disease, testing the drugs pf-06669571 and placebo. The eligibility criteria include a clinical diagnosis of Parkinson's disease, specific symptoms, and exclusion of atypical parkinsonian syndrome.",
    "This sample is a phase 1 clinical trial for patients with type 1 diabetes, testing the effectiveness of faster-acting insulin aspart and insulin aspart in individuals aged 18-64 with a BMI between 18.5-28.0 kg/m^2, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-Hodgkin lymphoma, testing the drugs entospletinib and vincristine, and includes eligibility criteria such as measurable disease, prior treatment history, performance status, and organ function.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory Hodgkin lymphoma, testing the effectiveness of brentuximab vedotin and nivolumab as treatment options, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial that includes patients with gastric cancer, gastroesophageal junction adenocarcinoma, non-small cell lung cancer, and hepatocellular carcinoma. The trial is testing the drugs ramucirumab and medi4736, and the eligibility criteria include having measurable metastatic disease or locally advanced and unresectable disease, specific histopathological confirmation, and adequate organ function.",
    "This sample is a phase 1/phase 2 trial for patients with symptomatic knee osteoarthritis, testing the effectiveness of hyaluronic acid as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for pancreatic cancer patients, testing the effectiveness of the drug combination gax (gemcitabine, abraxane, and xeloda), with specific eligibility criteria including measurable lesions, liver and bone marrow function, and exclusion criteria such as neuroendocrine cancer and hypersensitivity to taxanes.",
    "This sample is a phase 1 trial for type 1 diabetes mellitus, testing the drugs dapagliflozin and placebo tablet, with eligibility criteria including a diagnosis of T1DM, insulin use for at least 12 months, HbA1c levels between 7.0% and 10.0%, and a BMI between 20.0 kg/m\u00b2 and 35.0 kg/m\u00b2.",
    "This sample is a phase 1 trial testing the drugs cal02 low-dose, cal02 high-dose, and placebo for the treatment of severe pneumonia caused by Streptococcus pneumoniae in adult patients. The eligibility criteria include age, body weight, CURB-65 score, Streptococcus pneumoniae identification, and exclusion criteria such as other types of pneumonia, time since diagnosis and antibiotic treatment, scores for APACHE II and SOFA, and various medical conditions.",
    "This sample is a phase I trial for diabetic retinopathy, testing the drugs metformin, lantus, and novomix30, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1/phase 2 trial for patients with lymphoma, testing the effectiveness of lenalidomide, vorinostat, gemcitabine, busulfan, melphalan, rituximab, dexamethasone, caphosol, glutamine, pyridoxine, enoxaparin, and palifermin as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with myelofibrosis, testing the drugs ruxolitinib and vismodegib, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1/phase 2 trial for patients under 18 years old with end stage renal disease receiving in-center hemodialysis, testing the drug triferic, and assessing eligibility criteria such as adequate hemodialysis, suitable vascular access, iron-repletion, and stable ESA dose.",
    "This sample is a phase 1 trial for healthy volunteers, testing the drugs dsta4637s and placebo, with inclusion criteria including BMI between 18 and 32 kg/m^2 and good health, and exclusion criteria including history of drug abuse and abnormal ECG.",
    "This sample is a phase 1 trial for type 2 diabetes mellitus, testing the drugs metformin and hms5552, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for healthy individuals, testing the drugs ly3154207, placebo, and modafinil, with inclusion criteria including being overtly healthy males 18 years or older with a regular sleep pattern, and exclusion criteria including being shift workers, having a known sleep disorder, or having traveled 2 time zones or more within 7 days prior to screening.",
    "This sample is a phase 1/phase 2 trial for the treatment of influenza, testing the drugs oseltamivir, medi8852, and placebo, with eligibility criteria including age, symptoms, confirmed infection, and ability to complete the follow-up period.",
    "This sample is a phase 1/phase 2 trial investigating the use of tranexamic acid and ethamsylate in women undergoing elective caesarean section with risk factors for postpartum hemorrhage, while excluding patients with certain medical conditions.",
    "This sample is a phase 1 clinical trial for patients with metastatic melanoma, testing the combination of SGI-110 and ipilimumab as a treatment option. The eligibility criteria include having unresectable Stage III or Stage IV melanoma, prior treatment history, Eastern Cooperative Oncology Group (ECOG) performance status, negative screening tests, and specific exclusion criteria.",
    "This phase 1 trial is testing the drug AZD1775 in patients with locally advanced or metastatic solid tumors, including ovarian cancer, who have not responded to standard therapy, and have specific eligibility criteria related to their laboratory values, age, and disease status.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia, testing the combination of ibrutinib and obinutuzumab as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drug glpg1972 for healthy males between 18-50 years of age, with inclusion criteria including body mass index and good health, and exclusion criteria including hypersensitivity to the drug, concurrent participation in other research studies, and active drug or alcohol abuse.",
    "This sample is a phase 1/phase 2 clinical trial for patients with unresectable colorectal cancer, testing the combination of panitumumab and tas-102 as a treatment option for those who have failed previous chemotherapies, with specific eligibility criteria including age, tumor evaluation, KRAS/NRAS wild-type status, organ function, and performance status, among others.",
    "This sample is a phase 1 trial testing the combination of interferon-gamma and nivolumab in patients with advanced solid tumors, including RCC, UC, melanoma, NSCLC, and other tumor types, who have shown clinical or pre-clinical evidence of responding to anti-PD-1 therapy or up-regulating PD-L1.",
    "This sample is a phase 1 clinical trial for participants with schizophrenia, testing the effectiveness of tak-058 and ondansetron drugs compared to their placebos, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for the drug ser-287 in patients with ulcerative colitis, with specific inclusion and exclusion criteria listed.",
    "This sample is a phase 1 trial for patients with advanced or metastatic pancreatic adenocarcinoma who have failed or did not tolerate first-line therapy. The trial will test the effectiveness of chemotherapy, gemcitabine, irinotecan, leucovorin, 5-fluorouracil, and pembrolizumab in treating the disease. Eligibility criteria include having measurable disease, specific laboratory results within normal range, and willingness to comply with the treatment plan and visits.",
    "This sample is a phase 1 trial for the treatment of triple negative breast neoplasms using drugs such as nab-paclitaxel, anthracycline (doxorubicin), cyclophosphamide, carboplatin, and paclitaxel, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial testing the drug anlotinib and its labeled version for the treatment of advanced solid tumors, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for children and adolescents aged 7-18 years old with uncomplicated appendicitis, testing the use of ropivacaine and normal saline for laparoscopic appendectomy surgery.",
    "This sample is a phase 1/phase 2 trial testing the efficacy of melatonin oral gel 3% compared to placebo oral gel in patients with non-metastatic stage III-IV squamous cell carcinoma of the oral cavity, oropharynx, or any head and neck site with lymph nodes at cervical level II, or nasopharynx. Patients must have a treatment plan based on systemic treatment concurrent with radiation, and meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 clinical trial testing the effectiveness of various drugs, including cyclophosphamide and avelumab, in treating solid tumors, soft-tissue sarcoma, and breast cancer patients who meet specific eligibility criteria.",
    "This sample is a phase 1 clinical trial for endometrial cancer patients, testing the drugs mk-3475, paclitaxel, and carboplatin, with specific eligibility criteria and exclusion criteria.",
    "This phase 1 trial is testing the drugs ag-519 and placebo on healthy adult subjects with anemia, who must meet specific inclusion criteria such as being non-smokers and having a good state of health, while also excluding subjects who have participated in a clinical research study within the previous 3 months or have a history of drug or alcohol abuse in the past 2 years.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed or refractory follicular lymphoma, testing the combination of atezolizumab, lenalidomide, and obinutuzumab as a potential treatment option, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 trial for diabetes mellitus, testing the effects of human biphasic insulin and human biphasic insulin, reference on healthy male subjects aged 18-55 with a BMI between 18.5 and 28.0 kg/m^2 and fasting plasma glucose concentration <= 100 mg/dL. The inclusion and exclusion criteria include various medical conditions, surgeries, abnormal test results, and lifestyle factors that may affect the subject's safety or compliance during the trial.",
    "This sample is a phase 1 trial for patients with recurrent adult acute myeloid leukemia, testing the drugs cytarabine, ibrutinib, and idarubicin, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drug sorafenib on patients with incurable locally advanced or metastatic solid malignancy, who meet specific eligibility criteria.",
    "This sample is a phase 1/phase 2 trial testing the use of botox and saline in healthy volunteers between 18 and 50 years of age to evaluate itch and pain perception in individuals with pruritus, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for the drug vismodegib in the treatment of basal cell carcinoma, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with malignant pleural mesothelioma, testing the effectiveness of pemetrexed/cisplatin as a chemotherapy regimen, with specific inclusion and exclusion criteria for patient eligibility.",
    "This sample is a phase 1 trial for patients with chronic obstructive pulmonary disease (COPD), testing the drugs bi 1026706 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with various types of acute myeloid leukemia (AML), including recurrent childhood AML, secondary AML, and therapy-related AML. The trial aims to evaluate the efficacy and safety of a combination of drugs including cytarabine, fludarabine phosphate, and liposome-encapsulated daunorubicin-cytarabine. The eligibility criteria include specific disease characteristics, previous treatment history, performance status, and various laboratory parameters.",
    "This sample is a phase 1 clinical trial for patients with atopic dermatitis, testing the effectiveness of the drugs dupilumab, midazolam, omeprazole, warfarin, caffeine, and metoprolol, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for the drug GSK3389404 and a matching placebo in patients with hepatitis B. The eligibility criteria include being between 18 and 55 years old, having a body weight above a certain threshold, and meeting certain health requirements.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drug bpn14770 against a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with metastatic breast cancer, testing the drugs durvalumab and trastuzumab, with eligibility criteria including prior exposure to taxane, trastuzumab, and pertuzumab, and measurable disease as defined by RECIST 1.1.",
    "This sample is a phase 1 trial for patients with metastatic breast cancer and central nervous system (CNS) metastases, testing the combination of lapatinib and capecitabine as a treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the drugs chs-1701 and pegfilgrastim on healthy individuals, with specific inclusion and exclusion criteria, such as age, body weight, medical history, and previous exposure to pegfilgrastim or filgrastim.",
    "This sample is a phase 1 trial for healthy male subjects of Chinese or Japanese ethnicity, testing the drugs bi 1026706 and placebo, with inclusion and exclusion criteria outlined in the eligibility criteria section.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing the drugs elotuzumab and lenalidomide, and includes eligibility criteria such as age, disease status, prior treatment, and medical history.",
    "This sample is a phase 1 clinical trial for patients with metastatic breast, colon, or prostate cancer, testing the drug foxy-5. The eligibility criteria include having a documented diagnosis of refractory cancer, loss of Wnt-5a protein expression, and adequate organ function.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic breast cancer, testing the drugs vinorelbine and trastuzumab emtansine, with eligibility criteria including HER2-positive disease, prior treatment with a taxane, and normal organ and marrow function.",
    "This sample is a phase 1 clinical trial for patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma, testing the effectiveness of paclitaxel, ricolinostat, and bevacizumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial that includes healthy participants and participants with chronic hepatitis. The drugs being tested are jnj-56136379 and placebo, and the eligibility criteria include specific age ranges, BMI requirements, and negative pregnancy tests.",
    "This sample is a phase I trial investigating the use of aromatherapy with ginger, lavender, orange, and jojoba oils for managing chemotherapy symptoms in non-pregnant adults with cancer who are scheduled to receive at least three more cycles of chemotherapy. The inclusion criteria include age between 21 to 89 years, previous chemotherapy cycle, and a minimum 12-day gap between cycles. Exclusion criteria include age <21 or >89, pregnancy, chemotherapy-na\u00efve, more than four weeks between cycles, concurrent radiation therapy or interferon treatment, previous use of aromatherapy inhalation, and allergies to ginger, lavender, orange, citrus, jojoba, or essential oils.",
    "This sample is a phase 1 trial for patients with Tourette Syndrome, testing the drug sd-809, with inclusion criteria including age range, specific diagnosis and tic severity, and exclusion criteria including certain medications and psychiatric illnesses.",
    "This sample is a phase 1 clinical trial for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has relapsed or is refractory to chemotherapy, testing the efficacy of panobinostat, fludarabine, cytarabine, intrathecal triples, and leucovorin as treatment options. The eligibility criteria include age \u2264 24 years, adequate organ function, and fully recovered from prior therapy. Exclusion criteria include pregnancy, certain diseases, use of investigational agents within 30 days, and significant concurrent diseases or psychiatric disorders.",
    "This sample is a phase 1/phase 2 trial for patients with acute coronary syndrome, testing the drugs mdco-216 and placebo, with specific eligibility criteria including recent ACS event, qualifying myocardial infraction, and baseline coronary angiogram requirements.",
    "This sample is a phase 1 trial for patients with relapsed or refractory acute myeloid leukemia (AML), testing the drugs dasatinib, fludarabine, cytarabine, idarubicin, and intrathecal cytarabine, with specific eligibility criteria including histological confirmation, leukemic blasts in the bone marrow, and evidence of t(8;21) or inv(16) from initial diagnosis.",
    "This sample is a phase 1 clinical trial for patients with metastatic or non-resectable synovial sarcoma, testing the drug DHEA as a potential treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with colon cancer, testing the drug niclosamide, with specific eligibility criteria including confirmed diagnosis, performance status, age, hematologic, renal and hepatic function, and ability to provide informed consent.",
    "This sample is a phase 1 trial for patients with advanced/metastatic lung adenocarcinoma, testing the efficacy of different doses of apatinib in combination with docetaxel, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with high-risk smoldering multiple myeloma, testing the combination of ixazomib and dexamethasone as a potential treatment option.",
    "This sample is a phase 1 clinical trial for HIV patients, testing the drugs microgynon 30\u00ae and evotaz\u00ae to determine their safety and efficacy, with specific eligibility criteria for participants.",
    "This sample is a phase I clinical trial for the treatment of diabetic nephropathy using resveratrol, placebo, and losartan, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for hypertension, testing the drugs fimasartan, rosuvastatin, and fimasartan + rosuvastatin, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for breast cancer patients, testing the drugs entinostat, atezolizumab, and placebo, with eligibility criteria including confirmed triple negative breast carcinoma, measurable disease, prior lines of systemic therapy, and acceptable laboratory parameters.",
    "This sample is a phase 1 trial investigating the use of ionis angptl3-lrx and placebo in patients with hypertriglyceridemia and familial hypercholesterolemia, with specific inclusion and exclusion criteria for different cohorts based on disease diagnosis and lipid levels.",
    "This sample is a phase 1 trial for healthy male subjects, testing the safety and tolerability of dabigatran etexilate tablet and capsule formulations, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial testing the drug pf-06687234 and placebo on healthy individuals, with specific inclusion and exclusion criteria, and no specific diseases mentioned.",
    "This sample is a phase 1 clinical trial for patients with type 2 diabetes mellitus, testing the efficacy of insulin glargine/ lixisenatide fixed-ratio combination, insulin glargine, and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with hepatocellular carcinoma and liver cancer, testing the drugs mtl-cebpa and sorafenib 200mg, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing the drugs tremelimumab, durvalumab, and melphalan, with eligibility criteria including histologically confirmed multiple myeloma, measurable disease, available CD34+ stem cells, eligibility for autologous stem cell transplantation, and adequate organ function.",
    "This sample is a phase 1/phase 2 clinical trial for the drug pti-428 and placebo in patients with cystic fibrosis, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with unresectable melanoma, testing the drugs xl888, vemurafenib, and cobimetinib, and includes eligibility criteria such as confirmed BRAF V600 mutation, adequate organ function, and prior treatment restrictions.",
    "This sample is a phase 1 trial for patients with unresectable Stage III or Stage IV melanoma, testing the combination of TAK-580, TAK-202, vedolizumab, nivolumab, and ipilimumab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for the drug GSK3179106 and placebo in patients with irritable bowel syndrome, with inclusion criteria including age between 18 and 55, regular bowel habits, and specific contraception requirements for male subjects with female partners of childbearing potential, and exclusion criteria including previous diagnosis of IBS, liver disease, and positive pre-study drug/alcohol screen.",
    "This sample is a phase 1/phase 2 trial for patients with lymphoma, specifically those with prior treated diffuse large b-cell lymphoma, mantle cell lymphoma, transformed lymphoma, follicular lymphoma, small lymphocytic lymphoma, marginal zone lymphoma, or Hodgkin lymphoma. The drug being tested is tak228, and the eligibility criteria include factors such as age, consent, contraception, organ function, and measurable disease.",
    "This sample is a phase 1 clinical trial that aims to evaluate the effectiveness of mycophenolate mofetil and sirolimus in patients with various diseases such as acute myeloid leukemia, myelodysplastic syndrome, and non-Hodgkin lymphoma, among others, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase I clinical trial for patients with unresectable locally advanced or metastatic renal cell carcinoma, testing the drug pazopanib, and includes eligibility criteria such as prior therapy restrictions and organ function requirements.",
    "This sample is a phase 1/phase 2 trial for patients with estrogen-receptor positive and/or progesterone receptor positive breast cancer, testing the drugs ribociclib, everolimus, and exemestane, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with metastatic pancreatic cancer, testing the drugs galunisertib and durvalumab, with specific eligibility criteria including prior treatment history and organ function.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of diabetic foot infections using the drugs bisphosphocin nu-3 and placebo, with eligibility criteria including non-hospitalized ambulatory subjects suffering from Diabetes mellitus, Type I or II, and ulcerated areas of not more than two ulcers between 0.5 to 6 cm2.",
    "This sample is a phase 1 clinical trial for patients with ovarian, fallopian tube, or primary peritoneal cancer who have relapsed at least once and achieved complete clinical remission. The trial aims to evaluate the efficacy of nivolumab, an immunotherapy drug, in combination with vaccine therapy for patients with positive expression of WT1 or NY-ESO-1 proteins.",
    "This sample is a phase 1 trial testing the drugs \"mor106\" and \"placebo\" on healthy individuals and those with dermatitis, atopic, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for individuals with type 1 diabetes mellitus, testing the effectiveness of biochaperone human insulin, insulin lispro, and regular human insulin in managing the disease. The eligibility criteria include age, duration of diabetes, insulin treatment, BMI, HbA1c levels, and fasting C-peptide levels. Exclusion criteria include hypersensitivity to the drugs, type 2 diabetes, previous trial participation, recent participation in other trials, abnormal screening tests, gastrointestinal symptoms, gastric emptying issues, special diet requirements, and pregnancy/breastfeeding.",
    "This sample is a phase 1 trial for patients with advanced solid tumors, testing the combination of caffeine, warfarin, omeprazole, midazolam, digoxin, vitamin k, and rucaparib, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs duvortuxizumab and ibrutinib on patients with B-cell malignancies such as diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, or chronic lymphocytic leukemia, who have shown tumor progression following prior standard therapies. The study aims to evaluate the efficacy and safety of these drugs in treating these diseases.",
    "This sample is a phase 1/phase 2 clinical trial for the drugs \"mgv354 ophthalmic suspension\" and \"mgv354 placebo\" in patients diagnosed with open-angle glaucoma or confirmed ocular hypertension, with specific inclusion and exclusion criteria outlined in the criteria section.",
    "This sample is a phase I trial for patients with hypertension and high blood pressure, testing the effectiveness of losartan, amlodipine, and hydrochlorothiazide as antihypertensive medications, with specific inclusion and exclusion criteria for participation.",
    "This sample is a phase 1 clinical trial for patients with non-small-cell lung carcinoma, testing the drugs microgynon and nintedanib, with specific inclusion and exclusion criteria.",
    "This sample is a phase I trial for the treatment of treatment-resistant bipolar disorder using nitrous oxide as a potential therapy, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial that includes healthy participants and participants with type 2 diabetes mellitus (T2DM). The study will test the drugs LY3298176, placebo, and dulaglutide to evaluate their effectiveness in controlling T2DM. The eligibility criteria include specific BMI ranges and controlled T2DM with diet, exercise, or a single oral antidiabetic medication. Exclusion criteria include allergies to the study drugs and certain medical conditions such as pancreatitis or abnormal ECG.",
    "This sample is a phase 1 trial for hepatitis C, testing the drugs cdi-31244 and placebo, with eligibility criteria including age, body mass index, negative alcohol and drug screening, normal ECG results, and negative pregnancy test for females.",
    "This sample is a phase 1/phase 2 trial for patients with inoperable locally advanced esophageal cancer, testing the drug nab-paclitaxel, and includes eligibility criteria such as ECOG performance status scale 0-1 and normal cardiac function.",
    "This sample is a phase 1 trial that aims to evaluate the safety and efficacy of a tenofovir disoproxil fumarate intravaginal ring compared to a placebo intravaginal ring in HIV-uninfected women, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for healthy Japanese individuals, testing the drugs treprostinil, placebo, ly900014, and insulin lispro, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with type 2 diabetes, testing the efficacy of semaglutide compared to a placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with non-resectable, recurrent, or metastatic biliary tract carcinoma, testing the efficacy of the drug combination mek162+capecitabine, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with stage III or IV head and neck squamous cell carcinoma, testing the drug cisplatin, and includes eligibility criteria such as specific pathologic features, diagnostic workup, and various health parameters.",
    "This sample is a phase 1 trial for patients with asthma, testing the efficacy of different doses of abediterol in improving lung function, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with recurrent or refractory solid tumors or lymphoma, testing the drug entinostat, and includes eligibility criteria such as specific disease types, previous treatments, and required blood counts.",
    "This sample is a phase 1 clinical trial for patients with pancreatic ductal adenocarcinoma (PDAC) testing the effectiveness of the drug folfirinox (oxaliplatin, leucovorin, irinotecan) in combination with surgical resection as a treatment option.",
    "This sample is a phase 1 clinical trial for patients with chronic myelogenous leukemia (CML) who have failed previous treatments, and it aims to evaluate the efficacy of axitinib and bosutinib drugs in different phases of CML. The eligibility criteria include specific diagnosis requirements, performance status, and various laboratory values, while the exclusion criteria involve prior therapy with axitinib, certain medical conditions, and pregnancy.",
    "This sample is a phase 1 trial for patients with soft tissue sarcoma, testing the combination of olaratumab and doxorubicin as potential therapy, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs fr104 and placebo on subjects with rheumatoid arthritis and complications of transplant, with specific eligibility criteria including age, health condition, weight, negative drug and alcohol tests, and agreement to contraception use.",
    "This sample is a phase 1 trial for patients with relapsed or refractory lymphoma or non-hematologic malignancies, testing the drug pixantrone, with eligibility criteria including prior chemotherapy failure and specific cardiac and hematologic measurements.",
    "This sample is a phase 1/phase 2 clinical trial for patients with nasopharyngeal carcinoma, testing the effectiveness of cisplatin in combination with intensity-modulated photon radiation therapy (IMXT) for recurrent cases. The inclusion criteria include pathologically confirmed NPC, completed course of IMXT, recurrence diagnosed more than 12 months after initial treatment, age between 18 and 70, Karnofsky Performance Score \u226570, willingness to accept contraception for women of childbearing potential, ability to understand the trial's consequences, and willingness to sign informed consent. Exclusion criteria include local recurrence within 12 months of previous radiation therapy, presence of distant metastasis, use of technology other than IMXT for initial diagnosis, pregnancy or lactation, incomplete recovery from prior therapies, diagnosis of other malignancies within the past 5 years, and patient refusal to participate.",
    "This sample is a phase I trial for early stage breast cancer patients, testing the combination of oral vinorelbine and letrozole as neoadjuvant treatment, with specific eligibility criteria including postmenopausal status, HR-positive and HER2-negative breast cancer, and adequate organ function.",
    "This sample is a phase I trial for early-stage breast carcinoma, testing the drugs ME-344 and bevacizumab, with eligibility criteria including women over 18 years old, HER2-negative breast cancer patients not candidates for neoadjuvant therapy, and various organ function requirements.",
    "This sample is a phase 1/phase 2 trial for acidosis, testing the drugs placebo and trc101, with inclusion criteria including a specific range of estimated glomerular filtration rate and serum bicarbonate level, and exclusion criteria including certain comorbid conditions and anticipated changes in doses of specific drugs or drug classes.",
    "This sample is a phase 1/phase 2 trial for patients with stage III or stage IV melanoma, testing the drug imatinib mesylate. The eligibility criteria include having a confirmed diagnosis of melanoma, specific genetic mutations, and certain health parameters within normal ranges.",
    "This sample is a phase 1/phase 2 trial for chronic obstructive pulmonary disease (COPD) patients and healthy subjects, testing the drugs chf6297 and placebo in different parts of the study, with specific inclusion and exclusion criteria for each part.",
    "This sample is a phase 1/phase 2 trial testing the use of cannabidiol in patients diagnosed with Lennox-Gastaut syndrome or Dravet syndrome, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for HIV-1 infection, testing the efficacy of darunavir/cobicistat and etravirine as antiretroviral treatments, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for patients with refractory or relapsed acute lymphoblastic leukemia, testing the efficacy of dasatinib as an investigational agent, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drugs placebo and ro7105705, with specific inclusion and exclusion criteria for participants, including age range, cognitive abilities, and medical history.",
    "This sample is a phase 1 clinical trial for schizophrenia, testing the drugs placebo and ro5545965, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for a potential HIV treatment using the drugs 3bnc117, 10-1074, and placebo, with eligibility criteria including age, HIV status, medical history, and laboratory parameters.",
    "This sample is a phase 1 clinical trial testing the safety and efficacy of the drug vbi-1501a in healthy adults for the prevention of cytomegalovirus infections, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for the treatment of clostridium difficile infection (CDI) using the drug ser-262 and a placebo, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1 clinical trial that aims to evaluate the safety and efficacy of the drug combination tak-659 and nivolumab in treating advanced solid tumors, including triple-negative breast neoplasms, carcinoma, non-small-cell lung, and head and neck carcinoma, squamous cell. The eligibility criteria include age, performance status, contraception requirements, laboratory values, and prior treatment history.",
    "This sample is a phase 1 trial that aims to evaluate the efficacy of nintedanib and bevacizumab in patients with various advanced or metastatic solid cancers, including renal cell carcinoma, colorectal adenocarcinoma, non-squamous non-small cell lung cancer, platinum-refractory ovarian carcinoma, and cervical carcinoma. The eligibility criteria include age >18, histologically proven advanced or metastatic solid cancer, life expectancy of at least 3 months, ECOG performance status score 0-1, progression after first-line systemic therapy for metastatic disease, and adequate organ function. The exclusion criteria include previous serious dose-limiting toxicities with bevacizumab, hypersensitivity to nintedanib or trial drugs, recent therapy with chemo, hormone, radio, or immunotherapy, brain involvement with cancer, major cardiovascular diseases, and other significant medical conditions.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drug bpn14770 against a placebo, with specific eligibility criteria including age, body mass index, and contraceptive use for females.",
    "This sample is a phase 1/phase 2 trial for bladder cancer patients, testing the drugs vinflunine and cisplatin, with eligibility criteria including age, signed consent, confirmed tumor resection, ECOG performance status, and various health parameters.",
    "This sample is a phase 1 clinical trial for the drug elamipretide in patients with age-related macular degeneration, specifically those with intermediate AMD - noncentral GA or intermediate AMD - high-risk drusen without GA, and includes detailed eligibility criteria for inclusion and exclusion.",
    "This sample is a phase I trial testing the use of gabapentin, a medication commonly used for neuropathic pain, in patients with acute pain due to rib fractures, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for HIV-1 infection, testing the drugs vesatolimod, placebo, and an antiretroviral (ARV) regimen, with eligibility criteria including being on ARV treatment for at least 12 months, having plasma HIV-1 RNA levels below 50 copies/mL, and meeting various blood count and liver function requirements.",
    "This sample is a phase 1/phase 2 trial for patients with advanced or metastatic cutaneous, acral or mucosal melanoma, testing the drugs mrx34 and dexamethasone, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for ulcerative colitis, testing the drugs bms-986184 and placebo, with eligibility criteria including a negative pregnancy test for women of childbearing potential and a confirmed diagnosis of ulcerative colitis.",
    "This sample is a phase 1/phase 2 trial for post-menopausal women experiencing frequent moderate to severe hot flashes, testing the drugs bay3427080 and placebo for bay3427080, with inclusion criteria including post-menopausal status and exclusion criteria including BMI > 35kg/m2 and use of prohibited medications.",
    "This sample is a phase 1 trial for patients with functional dyspepsia, testing the drugs abx-1431 and placebo, with specific inclusion and exclusion criteria, including BMI, age, and medical history.",
    "This sample is a phase 1 clinical trial for asthma, testing the drugs xc8 (histamine glutarimide) and placebo, with inclusion criteria including age, good health, BMI, and contraception requirements, and exclusion criteria including diseases, laboratory abnormalities, medication use, and allergies.",
    "This sample is a phase 1/phase 2 trial for patients with relapsed acute myeloid leukemia (AML) who are ineligible for remission after systemic therapy. The study aims to evaluate the efficacy and safety of chidamide plus dcag regimen in these patients. The inclusion criteria include age between 18 and 59, AML diagnosis, relapse after remission or failure to achieve remission, ECOG performance status 0-3, expected survival time > 3 months, absence of serious heart/lung/liver/kidney disease, and no recent treatment. The exclusion criteria include allergy to the study drug, pregnancy/lactation/women of childbearing age without contraception, active infection, drug/alcohol abuse, mental disorders, significant cardiac history, organ transplantation, active bleeding, recent thrombosis/embolism/cerebral hemorrhage, recent surgery, bone marrow hyperplasia with low WBC count, liver/renal abnormalities, and investigator's assessment of unsuitability.",
    "This sample is a phase 1/phase 2 trial for patients with sarcoma, testing the drug doxorubicin hydrochloride, and includes eligibility criteria such as measurable disease, performance status, blood counts, liver and kidney function, and pregnancy status.",
    "This sample is a phase 1 clinical trial for patients with unresectable, stage III or metastatic melanoma, testing the combined dual immune-checkpoint blockade therapy with ipilimumab and nivolumab, and the eligibility criteria include measurable disease, specific organ and marrow function requirements, and exclusion of certain conditions and medications.",
    "This sample is a phase 1/phase 2 trial for non-small cell lung cancer (NSCLC) and carcinoma patients with ALK rearrangement, testing the efficacy of ensartinib and durvalumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with glioblastoma and malignant glioma, testing the drugs MRZ and TMZ, with specific eligibility criteria including age, performance status, prior treatments, and medical conditions.",
    "This sample is a phase 1/phase 2 clinical trial for Alzheimer's disease, testing the drugs ct1812 and placebo in subjects aged 50-80 with mild to moderate Alzheimer's disease, and includes eligibility criteria such as previous decline in cognition, neuroimaging consistent with Alzheimer's disease, MMSE score of 18-26, and stable use of acetylcholinesterase inhibitors or memantine.",
    "This sample is a phase 1 clinical trial that focuses on neoplasms, specifically lung neoplasms, and uses the drugs entinostat and pembrolizumab. The eligibility criteria include completing a previous study and resolving any adverse events or toxicities.",
    "This sample is a phase 1 trial for patients with biopsy-proven prostate cancer, who are planned to receive treatment with an androgen signaling inhibitor, and have at least one target lesion amenable to hyperpolarized C-13 pyruvate/metabolic MR imaging. The drug being tested is pyruvate (13c).",
    "This sample is a phase 1 trial for the treatment of depression using the drug naltrexone, targeting patients with major depressive disorder who have failed to respond to previous antidepressant therapies.",
    "This sample is a phase 1 trial testing the drugs apixaban and clarithromycin on subjects with venous thromboembolism, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with chronic lymphocytic leukemia (CLL) who are currently on treatment with ibrutinib, testing the combination of snx-5422 plus ibrutinib as a potential therapy option. The eligibility criteria include specific requirements for CLL diagnosis, prior treatment history, BTK mutation status, and overall health. Exclusion criteria include previous toxicity with ibrutinib, prior treatment with any Hsp90 inhibitor, recent surgery or traumatic injury, and certain gastrointestinal and liver conditions.",
    "This sample is a phase 1 clinical trial for arthroplasty, replacement, knee, testing the drugs ep=7041 and placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for type 2 diabetes mellitus, testing the effectiveness of various drugs including biochaperone\u00ae combo, humalog\u00ae mix25, humalog\u00ae, lantus\u00ae, and placebo, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1/phase 2 trial testing the drugs entinostat, avelumab, and placebo on patients with epithelial ovarian cancer, peritoneal cancer, and fallopian tube cancer who have had recurrent or progressive disease after platinum-based chemotherapy, and meet certain eligibility criteria.",
    "This sample is a phase 1 trial for patients with unresectable or metastatic BRAF V600 mutant melanoma, testing the effectiveness of digoxin combination, dabrafenib, and trametinib as potential treatments, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for lupus erythematosus, systemic, testing the drugs jnj-56022473 and placebo, with inclusion criteria including specific body weight and BMI ranges, meeting diagnostic criteria for lupus, and having a positive gene signature score, while exclusion criteria include drug-induced SLE, unstable lupus nephritis, and major surgery.",
    "This sample is a phase 1/phase 2 clinical trial for non-small cell lung cancer, testing the drugs gedatolisib, paclitaxel, and carboplatin, with eligibility criteria including advanced-stage unresectable NSCLC, prior chemotherapy allowance, and specific genetic mutations.",
    "This sample is a phase 1/phase 2 trial for patients with high or very high risk myelodysplastic syndromes (MDS) who have failed hypomethylating treatment, and it involves the drugs gsk2879552 and azacitidine.",
    "This sample is a phase 1 trial for patients with major depressive disorder, testing the drug diprivan, and includes specific eligibility criteria such as failed antidepressant treatments and certain scores on depression scales.",
    "This sample is a phase 1 trial for the treatment of schizophrenia using low dose aut00206, high dose aut00206, placebo, and ketamine, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for breast cancer patients with specific characteristics, such as cyclin D1 positivity and hormone receptor positivity, and it involves the drugs fulvestrant and tamoxifen.",
    "This sample is a phase 1 trial for patients with locally advanced squamous cell carcinoma of the head and neck, testing the drugs avelumab and cetuximab, with eligibility criteria including age, performance status, disease confirmation, and organ function requirements.",
    "This sample is a phase 1 trial for psoriasis, testing the drugs bay1003803, clobetasol propionate, and betamethasone/calcipotriene, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with locally advanced or metastatic cancer, testing the drugs NOX66 and carboplatin, with eligibility criteria including provision of informed consent, ECOG performance status 0-1, and adequate bone marrow, hepatic, and renal function.",
    "This sample is a phase 1 trial for healthy participants, testing the drugs dabigatran etexilate mesylate, odalasvir, and simeprevir for eligibility criteria including BMI, blood pressure, and non-smoking status. Exclusion criteria include liver or renal insufficiency, skin diseases, allergies to the drugs, and positive tests for hepatitis B or C.",
    "This sample is a phase 1 clinical trial for patients with breast neoplasm, specifically triple negative breast cancer, testing the effectiveness of cyclophosphamide, indomethacin, and omeprazole as part of neoadjuvant chemotherapy treatment, with specific inclusion and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for patients with multiple myeloma, testing the effectiveness of daratumumab, cyclophosphamide, bortezomib, and dexamethasone as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase I clinical trial for patients with Crohn's disease, testing the effectiveness of thalidomide and placebo in treating refractory cases, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the effectiveness of different contraceptive drugs (15 mg e4/3 mg drsp, 30 mcg ee/150 mcg lng, 20 mcg ee/3 mg drsp) on healthy adult women, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drugs rp3128 and placebo on healthy volunteers and patients with mild asthma, with specific inclusion and exclusion criteria, including BMI range, non-smoking status, and negative drug and alcohol screens.",
    "This sample is a phase 1 clinical trial testing the drug ensartinib in patients with advanced solid tumor malignancy, specifically non-small cell lung cancer metastatic with ALK genomic alterations positive by FISH or IHC, and it includes eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 trial for patients with prostate cancer, testing the effectiveness of copper, disulfiram, and copper gluconate drugs, with eligibility criteria including age, performance status, laboratory parameters, confirmed diagnosis of prostate cancer, evidence of metastatic disease, and previous use of certain therapies.",
    "This sample is a phase 1 clinical trial for ischemic stroke, testing the efficacy of different doses of ddfpe and placebo in patients who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 1/phase 2 clinical trial for patients with relapsed or refractory solid tumors and non-small cell lung cancer, testing the drugs lenalidomide and pembrolizumab, with eligibility criteria including measurable disease, prior therapy completion, normal organ function, and signed consent.",
    "This sample is a phase 1/phase 2 trial for Duchenne muscular dystrophy, testing the drug (+)-epicatechin, with inclusion criteria including confirmed diagnosis of DMD, non-ambulatory status, and stable cardiac and glucocorticoid therapy.",
    "This sample is a phase I clinical trial for patients with follicular lymphoma, testing the drug ibrutinib, and includes eligibility criteria such as completion of first-line immunochemotherapy and residual FDG-PET activity.",
    "This sample is a phase 1 clinical trial for chronic sinusitis, testing the drug mometasone furoate sinus drug depot, and includes inclusion and exclusion criteria for potential study subjects.",
    "This sample is a phase 1 clinical trial testing the drug sonazoid on patients with cutaneous melanoma and melanoma, with specific eligibility criteria and exclusion criteria.",
    "The sample is a phase I trial investigating the use of real-time heparin dose adjustment and standard heparin dose in patients undergoing surgical procedures for deep-venous thrombosis, pulmonary embolism, and venous thromboembolism, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with CLL who are currently on treatment with ibrutinib, testing the combination of snx-5422 plus ibrutinib as a potential therapy option.",
    "This sample is a phase 1/phase 2 clinical trial testing the effectiveness of brimonidine 0.15%, brimonidine 0.075%, and placebo in treating dry eye, ocular graft vs host disease, and meibomian gland dysfunction, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial testing the drug nivolumab in patients with hematologic malignancies who have undergone allogeneic stem cell transplant, and it includes detailed eligibility criteria for patient selection.",
    "This sample is a phase 1 trial for patients with advanced, unresectable hepatocellular carcinoma, testing the drugs sorafenib and bavituximab, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with chronic moderate or severe plaque psoriasis, testing the efficacy of a drug cocktail and ixekizumab in reducing symptoms, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for advanced solid tumors, testing the drugs avelumab and m9241, and includes eligibility criteria such as age, performance status, and adequate organ function.",
    "This sample is a phase 1/phase 2 trial for the treatment of psoriasis using GSK2981278 ointment and vehicle ointment, with eligibility criteria including a clinical diagnosis of stable plaque psoriasis, BSA involvement of 5-15%, and a PGA score of 2 or higher.",
    "This sample is a clinical trial study that focuses on the phase 1/phase 2 treatment of various diseases including anemia, B-cell prolymphocytic leukemia, follicular lymphoma, hairy cell leukemia, and mantle cell lymphoma using the drug entospletinib. The eligibility criteria include specific disease diagnoses, previous treatment regimens, and certain medical conditions.",
    "This sample is a phase 1 clinical trial for the treatment of perianal fistula in patients with Crohn's disease, using MSC-AFP as the only treatment option, and includes eligibility criteria such as age, residency, previous failed therapies, and exclusion criteria such as medical conditions, infections, and allergies.",
    "This sample is a phase 1/phase 2 trial for patients with non-small-cell lung carcinoma, testing the drugs atezolizumab and daratumumab, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 clinical trial for patients with symptomatic multiple myeloma, testing the effectiveness of the drugs nivolumab, pomalidomide, dexamethasone, and elotuzumab, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for healthy individuals, testing the drugs ly3192767, basal insulin peglispro, insulin glargine, and placebo, with inclusion criteria including being overtly healthy and having a BMI between 18.5 and 30.0 kg/m\u00b2.",
    "This sample is a phase 1/phase 2 trial for small cell lung cancer (SCLC) patients with progressive disease after platinum-based chemotherapy, testing the drugs ipilimumab, nivolumab, and rovalpituzumab tesirine, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with metastatic colorectal cancer, testing the drugs brontictuzumab and trifluridine/tipiracil, with specific eligibility criteria including prior treatment history and performance status.",
    "This sample is a phase 1/phase 2 clinical trial for patients with small cell lung cancer, testing the combination of ipilimumab and nivolumab drugs after platinum-based chemotherapy, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for men with metastatic castrate-resistant prostate cancer who have received at least 4 cycles of docetaxel or cabazitaxel, and less than ten, with two consecutive rising PSA values, checked at least 7 days apart, and have bone disease documented by either a positive bone scan, CT scan, or MRI; or biopsy-proven bony metastases. The study aims to evaluate the safety and efficacy of docetaxel, cabazitaxel, and clarithromycin in this patient population.",
    "This sample is a phase 1 trial testing the efficacy of hyaluronic acid and hyaluronic acid with corticosteroids in treating knee osteoarthritis, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase I trial for patients with fatigue and overheating, testing the effects of acetylsalicylic acid and placebo on RRMS patients with low physical disability and no recent exacerbations, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for HIV patients, testing the drugs clopidogrel and prasugrel, with specific inclusion and exclusion criteria related to renal and hepatic function, smoking, drug allergies, and bleeding risk.",
    "This sample is a phase 1 clinical trial for patients with chronic discogenic low back pain, testing the drugs sta363 and placebo, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for participants with Type 1 Diabetes Mellitus (T1DM) who are receiving insulin therapy via an approved insulin pump. The study aims to evaluate the safety and efficacy of LY900014 and insulin lispro (Humalog) in managing T1DM.",
    "This sample is a phase 1 clinical trial for patients with small bowel carcinoid tumor, testing the effects of Ga-68-DOTA-TOC and lar octreotide drugs, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with Tourette Syndrome or chronic motor tic disorder, testing the drugs abx-1431 and placebo comparator, with eligibility criteria including age, diagnosis, tic severity scale results, and stable medication use.",
    "This sample is a phase 1/phase 2 clinical trial for the treatment of moderate to severe atopic dermatitis using hat1 topical cream and vehicle cream, with eligibility criteria including age range, exclusion of certain medical conditions, and restrictions on medication use.",
    "This sample is a phase 1/phase 2 trial for patients with recurrent and/or metastatic breast cancer, testing the drug cyclophosphamide, with eligibility criteria including histological confirmation of breast cancer, evidence of persistent, recurrent, or progressive disease, expected survival of at least 4 months, and adequate performance status.",
    "This sample is a phase 1 clinical trial for ulcerative colitis, testing the drug top1288 and placebo to top1288, with inclusion criteria including being a healthy male aged 18-55, having a BMI between 18.0 and 29.9 kg/m2, and having regular bowel movements, and exclusion criteria including participation in another study within the last 3 months, positive tests for HIV or hepatitis, history of alcohol or drug abuse, and history of certain medical conditions affecting the colon or rectum.",
    "This sample is a phase 1 clinical trial testing the drug ticagrelor on healthy individuals with specific inclusion and exclusion criteria, including age, sex, ethnicity, and good health.",
    "This sample is a phase 1 trial for patients diagnosed with Chronic Rhinosinusitis with Nasal Polyps, testing the effectiveness of verapamil hydrochloride intranasal as a treatment option, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with BCG unresponsive non-muscle-invasive bladder cancer, testing the effectiveness of nivolumab, an anti-PD-1 antibody, as a treatment option.",
    "This sample is a phase 1/phase 2 trial for patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS), testing the drugs decitabine and digoxin, with inclusion criteria including confirmed diagnosis of AML or INT-2/high-risk MDS, age > 18 years, normal organ function, and willingness to sign informed consent, while exclusion criteria include recent chemotherapy or radiotherapy, brain metastases, active infection, prior digoxin exposure, and certain medication interactions.",
    "This sample is a phase 1 clinical trial for Alzheimer's disease, testing the drugs abvac40 and placebo, with eligibility criteria including a clinical diagnosis of Alzheimer's disease, specific MRI criteria, and a stable caregiver.",
    "This sample is a phase 1 trial for small cell lung cancer (SCLC) patients with extensive disease, testing the drugs m3814, cisplatin, and etoposide, and includes eligibility criteria such as age, diagnosis, disease stage, and performance status.",
    "This sample is a phase 1 trial for patients with nasopharyngeal carcinoma, testing the effectiveness of gemcitabine and cis-platinum as a systemic chemotherapy treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial testing the effectiveness of thiamine and placebos in treating septic shock, shock, septic, lactic acidosis, and thiamine deficiency. The eligibility criteria include age over 18, presence of sepsis, SIRS criteria, lactate level above 3mmol/L, hypotension, and vasopressor dependence. Exclusion criteria include cirrhosis or chronic liver disease, current thiamine supplementation, clinical indication for thiamine, comfort measures only designation, inability to provide consent, and other causes for lactate elevation.",
    "This sample is a phase 1 trial for healthy female participants of childbearing potential, testing the coadministration of JNJ-64155806 and ethinylestradiol/drospirenone contraception, with specific inclusion and exclusion criteria.",
    "This sample is a clinical trial for a drug called alectinib, which is being tested for the treatment of various types of lung cancer and thyroid cancer that carry specific genetic mutations (RET rearrangement or ALK rearrangement). The trial is divided into three phases (phase 1, phase 2 Cohorts A&B, and phase 2 Cohort C) and has specific eligibility criteria for enrollment, including prior treatment history, disease status, and organ function.",
    "This phase 1 trial is investigating the use of cyclophosphamide and alemtuzumab in patients with non-Hodgkin lymphoma, including high-grade B-cell lymphoma and diffuse large B-cell lymphoma, who are ineligible for standard curative therapeutic options.",
    "This sample is a phase 1 trial testing the drugs entospletinib, daunorubicin, and cytarabine for the treatment of hematologic malignancies, specifically acute myeloid leukemia, with specific eligibility criteria for participants.",
    "This sample is a phase I clinical trial for patients with COPD and pulmonary hypertension, testing the efficacy of inhaled nitric oxide as a treatment option. The eligibility criteria include a confirmed diagnosis of COPD, specific pulmonary hypertension measurements, and a history of tobacco smoking.",
    "This sample is a phase 1 trial for asthma patients, testing the drugs bi 443651 and placebo, with eligibility criteria including a diagnosis of asthma, specific spirometric criteria, age range, ACQ value, PD20 value, BMI range, and ability to perform study procedures. Exclusion criteria include significant pulmonary diseases, recent respiratory tract infection or asthma exacerbation, hospitalization or intubation for asthma, high serum potassium, recent blood donation, recent use of certain asthma medications, use of diuretics or drugs that may influence trial results, prolonged QT/QTc interval, history of risk factors for Torsades de Points, relevant allergies/hypersensitivities, and smoking history.",
    "This sample is a phase 1/phase 2 trial for patients with metastatic renal cell carcinoma, testing the efficacy of tivozanib and nivolumab as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial for a drug called ASN002, which is being tested for the treatment of chronic atopic dermatitis. The trial aims to evaluate the safety and efficacy of ASN002 compared to a placebo, and includes eligibility criteria such as having a certain percentage of body surface area affected by dermatitis, a history of inadequate response to other treatments, and willingness to comply with study procedures.",
    "This sample is a phase 1 clinical trial for asthma patients, testing the drugs azd9898 and matching placebo. The eligibility criteria include age, BMI, and asthma diagnosis, while the exclusion criteria include various medical conditions, substance use, and previous participation in the study.",
    "This sample is a phase 1 clinical trial for psoriasis, testing the drugs abbv-553 and placebo, with eligibility criteria including age, gender, BMI, general health condition, and specific criteria for subsudy 2.",
    "This sample is a phase 1/phase 2 trial for rheumatoid arthritis (RA) patients who are severely active and have started etanercept treatment within the last 3 months. The study aims to evaluate the efficacy of niclosamide and etanercept compared to a placebo in treating RA. The inclusion and exclusion criteria are specified, including restrictions on NSAID and MTX use, hypersensitivity to niclosamide, renal and hepatic impairment, pregnancy or breastfeeding, and the presence of other connective tissue diseases or hypothyroid disease.",
    "This sample is a phase 1 trial for patients with type 1 diabetes mellitus, testing the effectiveness of biochaperone\u00ae insulin lispro, fiasp\u00ae, and novorapid\u00ae in managing the disease, with specific eligibility criteria for inclusion and exclusion.",
    "This sample is a phase 1 trial for Alzheimer's disease, testing the drugs np001 and placebo, with eligibility criteria including age, diagnosis, cognitive scores, and exclusion criteria such as other neurologic disorders and unstable medical illness.",
    "This sample is a phase I clinical trial for patients with squamous cell carcinoma of the head and neck, testing the drug ribociclib, and includes eligibility criteria such as specific disease types, organ function requirements, and exclusion criteria such as hypersensitivity to the drug or concurrent malignancy requiring treatment.",
    "This sample is a phase 1/phase 2 trial investigating the use of sildenafil vaginal suppositories in women with infertility, specifically those with normal ovarian reserve and a history of failed IVF/ICSI attempts. The inclusion criteria include factors such as FSH levels, prior IVF/ICSI attempts, endometrial thickness, and normal endometrial appearance, while exclusion criteria include conditions like PCOS, myomectomy, Asherman's Syndrome, and mullerian anomalies.",
    "This sample is a phase 1/phase 2 trial for individuals with HIV infections, testing the combination of disulfiram and vorinostat drugs to reverse HIV latency, with specific inclusion and exclusion criteria.",
    "This sample is a phase I clinical trial for patients with urothelial carcinoma, testing the drugs atezolizumab and radium-223, with specific eligibility criteria including histologic diagnosis, bone metastasis, ECOG performance status, and progression of disease after platinum-containing chemotherapy.",
    "This sample is a phase 1/phase 2 clinical trial for cystic fibrosis, testing the drugs iva, tez/iva, vx-445, matched placebo, tez, and vx-561, with specific eligibility criteria including age, body mass index, CFTR genotype, and FEV1 value.",
    "This sample is a phase I clinical trial for nicotine dependence, testing the drugs mifepristone and placebo, with specific inclusion and exclusion criteria for male smokers aged 18 to 55 years.",
    "This sample is a phase I trial investigating the use of direct acting anti-viral therapy using epclusa or zepatier in patients with kidney transplant and hepatitis C, with specific inclusion and exclusion criteria for eligibility.",
    "This sample is a phase 1 trial for neovascular age-related macular degeneration, testing the drugs gb-102 and aflibercept, with key inclusion criteria including age \u2265 50, presence of an active CNV lesion, and evidence of increased vascular permeability and/or loss of visual acuity. Key exclusion criteria include a history of cardiac events, uncontrolled hypertension or diabetes, chronic renal disease, abnormal liver function, and pregnancy or lactation.",
    "This sample is a phase 1 clinical trial for patients with hepatocellular carcinoma, testing the drug meclizine oral tablet, and includes eligibility criteria such as confirmed imaging of the disease, no prior treatment for HCC, normal organ function, and willingness to use contraception.",
    "This sample is a phase 1/phase 2 trial for patients with myelodysplastic syndromes, testing the effectiveness of drugs such as nivolumab, azacitidine, and fludarabine, among others, with specific inclusion and exclusion criteria.",
    "This sample is a phase I clinical trial for patients diagnosed with schizophrenia who are receiving a stable dose of clozapine and aims to test the administration of vorinostat oral capsules as a potential treatment option, while excluding patients taking specific psychotropic medications and those with certain medical conditions or contraindications to vorinostat.",
    "This sample is a phase I trial for the treatment of pulmonary hypertension, testing the effectiveness of albuterol and placebo in patients with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 clinical trial for the treatment of chronic hepatitis B, testing the drugs eyp001a, placebo, entecavir, and peg-interferon alfa-2a, with eligibility criteria including documented positive HBsAg and HBV DNA levels, specific age and BMI ranges, normal lab test results, and various exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with inoperable, locally advanced or metastatic pancreatic cancer, testing the drug plerixafor, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 clinical trial for patients with metastatic colorectal cancer, testing the combination of irinotecan and capecitabine as a treatment option, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the effectiveness of cytisine, a drug used for smoking cessation, on regular moderate cigarette smokers who want to quit smoking. The eligibility criteria include being a healthy male or female between 18-65+ years of age, having certain levels of urine cotinine and expired air carbon monoxide, and having no clinically significant abnormalities in various tests. Exclusion criteria include recent use of smoking cessation medications, hypersensitivity to cytisine or its derivatives, and current treatment with certain medications.",
    "This sample is a phase 1 clinical trial for the treatment of lung diseases, including cystic fibrosis, using inhaled snsp113 and a placebo, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1/phase 2 trial for a drug called bay1817080 and a matching placebo, targeting refractory chronic cough in patients who have not responded to targeted treatment for underlying triggers such as reflux disease, asthma, and post-nasal drip. The eligibility criteria include age restrictions, non-smoking history, and the use of contraception for sexually active participants.",
    "This sample is a phase 1 trial for osteoarthritis, testing the drugs glpg1972 cohort 1, glpg1972 cohort 2, glpg1972 cohort 3, and placebo, with inclusion criteria including age, diagnosis of OA, BMI range, and good health, and exclusion criteria including recent injections, hypersensitivity to study drug ingredients, immunosuppressive condition, and history of malignancy.",
    "This sample is a phase 1 trial testing the drugs omnitram, tramadol, and placebo for the treatment of pain, with eligibility criteria including age between 18 and 50, normal vital signs, adequate hematologic and liver function, negative pregnancy and substance abuse tests, and exclusion criteria such as history of seizures or liver disease, use of certain medications, and unstable acute or chronic diseases.",
    "This sample is a phase 1 trial testing the use of nasal and intramuscular glucagon in patients with type 1 diabetes mellitus who have been on insulin therapy for at least 2 years, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with Hodgkin's lymphoma who have relapsed or are refractory to prior treatments, and are relapsed or refractory to nivolumab treatment. The study will test the effectiveness of nivolumab and bendamustine hydrochloride as potential treatments.",
    "This sample is a phase 1 trial for patients with diffuse large B-cell lymphoma or mediastinal B-cell lymphoma, testing the effectiveness of idelalisib, rituximab, ifosfamide, carboplatin, and etoposide as treatment options, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial testing the drugs atezolizumab, emactuzumab, and obinutuzumab for the treatment of non-Hodgkin lymphoma, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1/phase 2 trial for the drug \"gsk2798745\" and placebo in patients with chronic idiopathic cough, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with hepatocellular carcinoma, testing the combination of nivolumab and bevacizumab as a second-line therapy option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial testing the drugs ds-8201a, ritonavir, and itraconazole on patients with unresectable or metastatic solid malignant tumors that are refractory to or intolerable with prior chemotherapy, and have HER2 expression.",
    "This sample is a phase 1/phase 2 clinical trial for patients with BRAF V600 mutation-positive unresectable and/or metastatic malignant cutaneous melanoma, testing the combination therapy of dabrafenib and trametinib, with eligibility criteria including confirmed mutation, disease progression, and ECOG Performance Status of 0 or 1.",
    "This sample is a phase 1 trial testing the drugs bupivacaine low, bupivacaine high, and neosaxitoxin for anesthesia and analgesia in subjects who meet specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for healthy participants, testing the drugs al-794 and placebo, with inclusion criteria including BMI range, negative pregnancy test for females, and exclusion criteria including abnormal laboratory results and positive screening tests for HIV and hepatitis.",
    "This sample is a phase 1 trial for the treatment of amyloidosis using drugs such as gsk2315698 and gsk2398852, with specific eligibility criteria including age, disease confirmation, and stable heart condition.",
    "This sample is a phase 1 clinical trial for patients with advanced or metastatic solid tumors or lymphoma, testing the drugs mln9708 and nelfinavir. The eligibility criteria include specific requirements for creatinine levels, blood counts, and performance status, as well as contraception guidelines for female and male patients. The exclusion criteria include various medical conditions, recent surgeries or radiotherapy, and allergies to study medications.",
    "This sample is a phase 1 clinical trial for atopic dermatitis, testing the drugs sb414 2%, sb414 6%, and vehicle, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 trial for the treatment of psoriasis using the drugs sb414 6% and vehicle, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase 1 clinical trial for the treatment of pulmonary arterial hypertension using treprostinil inhalation powder, with specific inclusion and exclusion criteria for eligible participants.",
    "This sample is a phase 1 trial for asthma patients, testing the effects of itraconazole powder and itraconazole 200 mg on lung function, with specific inclusion and exclusion criteria for participants.",
    "This sample is a phase I clinical trial for patients with pancreatic ductal adenocarcinoma, testing the efficacy of pegylated recombinant human hyaluronidase and avelumab as a first-line treatment option, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 clinical trial testing the safety and efficacy of multiple drugs, including pb2452 infusion and ticagrelor oral tablet, in healthy subjects with specific inclusion and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial investigating the use of nitric oxide in patients with coronary artery disease requiring coronary artery bypass grafting, with specific inclusion and exclusion criteria. The study aims to evaluate the effects of nitric oxide on reperfusion injury and myocardial function.",
    "This sample is a phase 1 trial for patients with relapsed or refractory multiple myeloma, testing lenalidomide, melphalan, and plerixafor as treatment options, with specific eligibility criteria including NY-ESO-1 positivity and HLA-A*0201 positivity.",
    "This sample is a phase 1/phase 2 trial testing the drug gemcabene for the treatment of familial partial lipodystrophy, hypertriglyceridemia, fatty liver, and nonalcoholic steatohepatitis (NASH), with specific eligibility criteria including clinical diagnosis, genetic diagnosis, hepatic steatosis, triglyceride levels, and BMI.",
    "This sample is a phase 1 clinical trial that aims to evaluate the efficacy of vorolanib, nivolumab, and pembrolizumab in treating various types of solid tumors, including hepatocellular carcinoma, gastric cancer, and gastroesophageal junction adenocarcinoma, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for patients with castration-resistant prostate cancer, testing the drug cyclophosphamide. The inclusion criteria include confirmed adenocarcinoma of the prostate, radiographically documented metastatic disease, and previous progression following various therapies. The exclusion criteria include neuroendocrine or small cell cancer of the prostate, history of other malignant diseases, and recent administration of experimental or immunotherapy treatments.",
    "This sample is a phase 1/phase 2 clinical trial for patients with Parkinson's disease, testing the drugs IRL790 and placebo. The inclusion criteria include being aged 50-85, having a diagnosis of idiopathic PD, and showing a clear peak-dose dyskinetic response to regular L-Dopa medication. The exclusion criteria include a history of clinically significant diseases or disorders, psychiatric diagnosis, seizures, hepatic or renal disease, and recent illness or surgery.",
    "This sample is a phase 1 trial for patients with recurrent or refractory central nervous system lymphoma or diffuse large b-cell lymphoma, testing the drug lenalidomide as a potential treatment option. The eligibility criteria include specific disease characteristics, performance status, blood counts, and organ function, among others.",
    "This sample is a phase 1/phase 2 clinical trial for patients with metastatic prostate cancer or endometrial cancer, testing the drugs rucaparib and nivolumab. The eligibility criteria include specific disease requirements, prior treatments, and normal organ function.",
    "This sample is a phase 1 trial for knee osteoarthritis, testing drugs such as cntx-4975-05, qutenza, and lidocaine, with key inclusion criteria including BMI between 18.0-35.0 kg/m^2 and confirmation of osteoarthritis in the index knee.",
    "This sample is a phase 1 clinical trial testing the drug ly3322207 and placebo in healthy males and females with hypertension, who meet specific inclusion criteria and do not have any exclusion criteria.",
    "This sample is a phase 1/phase 2 trial for inguinal hernia repair, testing the drugs tlc590 and naropin, with eligibility criteria including age, ASA physical status, BMI, and exclusion criteria such as abnormal lab tests, history of seizures, and concurrent opioid therapy.",
    "This sample is a phase I trial for patients with locally advanced pancreatic cancer, borderline pancreatic inoperable cancer, or pancreatic cancer, testing the effectiveness of folfirinox and gemcitabine nab-paclitaxel as treatment options, with specific eligibility criteria and exclusion criteria outlined.",
    "This sample is a phase 1 trial for patients with various lymphomas and lymphoproliferative disorders, testing the drug pacritinib, and includes detailed eligibility criteria and exclusion criteria.",
    "This sample is a phase 1/phase 2 trial testing the drug febuxostat for the treatment of tumor lysis syndrome in patients of various age groups, with specific inclusion and exclusion criteria.",
    "This sample is a phase I trial for patients with rheumatoid arthritis, testing the effectiveness of steroids in resolving inflammation in the atlantoaxial joint, with specific inclusion and exclusion criteria.",
    "This sample is a phase 1 trial for patients with recurrent or metastatic squamous cell carcinoma of the head or neck, testing the drugs nivolumab and afatinib, with specific eligibility criteria and exclusion criteria.",
    "This sample is a phase 1 trial for patients with relapsed or refractory acute leukemia, testing the effectiveness of anti-CD123 CAR-T treatment, with specific eligibility criteria including confirmation of CD123 positivity, performance status score, kidney and liver function, and previous treatment timelines.",
    "This sample is a phase 1/phase 2 clinical trial for patients with multiple myeloma in relapse or progression, testing the efficacy of tinostamustine as consolidation therapy followed by autologous stem cell transplantation.",
    "This sample is a phase 1 trial for patients with relapsed/refractory precursor cell lymphoblastic leukemia-lymphoma, testing the drug ixazomib, with specific eligibility criteria including prior therapeutic attempts and recovery from acute toxic effects of prior treatments.",
    "This sample is a phase 1 trial for patients with HER2-positive breast cancer, testing the drugs copanlisib and trastuzumab emtansine in combination, with eligibility criteria including prior treatment with trastuzumab and a taxane, and at least one measurable lesion according to RECIST criteria."
]
